Ohio | 34-1730488 | ||||||||||
(State or other jurisdiction | (I.R.S. Employer Identification No.) | ||||||||||
of incorporation or organization) | |||||||||||
33587 Walker Road, | |||||||||||
Avon Lake, Ohio
|
44012 | ||||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
Common Shares, par value $.01 per share | AVNT | New York Stock Exchange |
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
Specialty Engineered Materials | Color, Additives and Inks | Distribution | ||||||||||||||||||
1. Birmingham, Alabama | 1. Glendale, Arizona | 30. Toronto, Canada | 60. Butterworth, Malaysia | 1. Rancho Cucamonga, California | ||||||||||||||||
2. Englewood, Colorado | 2. & 3. Phoenix, Arizona (c) | 31. Maipu, Chile | 61. Santa Clara, Mexico | 2. Chicago, Illinois | ||||||||||||||||
3. Montrose, Colorado | 4. Bethel, Connecticut | 32. Chuzhou, China | 62. Toluca, Mexico | 3. Eagan, Minnesota | ||||||||||||||||
4. North Haven, Connecticut | 5. Dalton, Georgia | 33. Guangzhou, China | 63. Eindhoven, Netherlands | 4. Edison, New Jersey | ||||||||||||||||
5. McHenry, Illinois | 6. Kennesaw, Georgia | 34. Pudong, China | 64. Auckland, New Zealand | 5. Statesville, North Carolina | ||||||||||||||||
6. Winona, Minnesota | 7. Elk Grove Village, Illinois | 35., 36. & 37. Shanghai, China (d) | 65. Karachi, Pakistan | 6. Elyria, Ohio | ||||||||||||||||
7. Hickory, North Carolina | 8. West Chicago, Illinois | 38. Suzhou, China | 66. Lahore, Pakistan | 7. La Porte, Texas | ||||||||||||||||
8. Avon Lake, Ohio | 9. La Porte, Indiana | 39. Tianjin, China | 67. Lima, Peru | 8. Brampton, Ontario, Canada | ||||||||||||||||
9. Hatfield, Pennsylvania | 10. Lewiston, Maine | 40. Cota, Colombia | 68. Konstantynow, Poland | (8 Distribution Facilities) | ||||||||||||||||
10. Changzhou, China | 11. Holden, Massachusetts | 41. Aland, Finland | 69. Kutno, Poland | |||||||||||||||||
11. Shenzhen, China | 12. Albion, Michigan | 42. Cergy, France | 70. Jeddah, Saudi Arabia | |||||||||||||||||
12. Suzhou, China | 13. Minneapolis, Minnesota | 43. Saint-Jeoire, France | 71. Riyadh, Saudi Arabia | |||||||||||||||||
13. Gaggenau, Germany | 14. St. Louis, Missouri | 44. Tossiat, France | 72. Yanbu, Saudi Arabia | |||||||||||||||||
14. Melle, Germany | 15. Lockport, New York | 45. Ahrensburg, Germany | 73. Randburg, South Africa | |||||||||||||||||
15. Leeuwarden, Netherlands | 16. Mooresville, North Carolina | 46. Diez, Germany | 74. Alicante, Spain | |||||||||||||||||
16. Barbastro, Spain | 17. Berea, Ohio | 47. Lahnstein, Germany | 75. Barcelona, Spain | |||||||||||||||||
17. Istanbul, Turkey | 18. Massillon, Ohio | 48. Guatemala City, Guatemala | 76. Pamplona, Spain | |||||||||||||||||
18. Leek, United Kingdom | 19. North Baltimore, Ohio | 49. Gyor, Hungary | 77. Sant Andreu, Spain | |||||||||||||||||
Shanghai, China (b) | 20. Norwalk, Ohio | 50. Kalol, India | 78. Malmoe, Sweden | |||||||||||||||||
Pune, India (a) | 21. Lehigh Valley, Pennsylvania | 51. Pune, India | 79. Taoyuan, Taiwan | |||||||||||||||||
Pamplona, Spain (a) | 22. Mountain Top, Pennsylvania | 52. Rania, India | 80. Bangkok, Thailand | |||||||||||||||||
(18 Manufacturing Plants) | 23. Vonore, Tennessee | 53. Vashere, India | 81. Phan Thong, Thailand | |||||||||||||||||
24. Winchester, Virginia | 54. Tangerang, Indonesia | 82. Gazientep, Turkey | ||||||||||||||||||
25. Lomas de Zamora, Argentina | 55. Naas, Ireland | 83. Gebze, Turkey | ||||||||||||||||||
26. Assesse, Belgium | 56. Lomagna, Italy | 84. Knowsley, United Kingdom | ||||||||||||||||||
27. Louvain-La-Nueve, Belgium | 57. Merate, Italy | 85. Thuan An, Vietnam | ||||||||||||||||||
28. Itupeva, Brazil | 58. Milan, Italy | (85 Manufacturing Plants) | ||||||||||||||||||
29. Suzano, Brazil | 59. Pogliano, Italy |
Name | Age | Position | ||||||||||||
Robert M. Patterson | 48 | Chairman, President and Chief Executive Officer | ||||||||||||
Jamie A. Beggs | 44 | Senior Vice President, Chief Financial Officer | ||||||||||||
Cathy K. Dodd | 55 | Senior Vice President, President of Distribution | ||||||||||||
Michael A. Garratt | 57 | Senior Vice President, President Color, Additives and Inks, EMEA | ||||||||||||
Lisa K. Kunkle | 52 | Senior Vice President, General Counsel and Secretary | ||||||||||||
M. John Midea, Jr. | 56 | Senior Vice President, Global Operations and Process Improvement | ||||||||||||
Woon Keat Moh | 47 | Senior Vice President, President of Color, Additives and Inks, Americas and Asia | ||||||||||||
Chris L. Pederson | 54 | Senior Vice President, President of Specialty Engineered Materials | ||||||||||||
Joel R. Rathbun | 48 | Senior Vice President, Mergers & Acquisitions | ||||||||||||
João José San Martin Neto | 60 | Senior Vice President, Chief Human Resources Officer |
Period | Total Number of Shares Purchased | Weighted Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program |
Maximum Number of Shares that May Yet be Purchased Under the Program(1)
|
|||||||||||||||||||
October 1 to October 31 | — | $ | — | — | 1,107,472 | ||||||||||||||||||
November 1 to November 30 | 150,000 | $ | 31.85 | 150,000 | 957,472 | ||||||||||||||||||
December 1 to December 31 | 100,000 | $ | 40.05 | 100,000 | 5,857,472 | ||||||||||||||||||
Total | 250,000 | $ | 35.59 | 250,000 |
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Sales | $ | 3,242.1 | $ | 2,862.7 | $ | 2,881.0 | ||||||||||||||
Operating income | 189.3 | 156.8 | 178.6 | |||||||||||||||||
Net income from continuing operations, net of income taxes | 133.8 | 75.7 | 87.4 | |||||||||||||||||
Net income from continuing operations attributable to Avient common shareholders | 132.0 | 75.5 | 87.7 |
Results of Operations | Variances — Favorable (Unfavorable) | |||||||||||||||||||||||||||||||||||||||||||
2020 versus 2019
|
2019 versus 2018
|
|||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions, except per share data) | 2020 | 2019 | 2018 | Change |
%
Change |
Change |
%
Change |
|||||||||||||||||||||||||||||||||||||
Sales | $ | 3,242.1 | $ | 2,862.7 | $ | 2,881.0 | $ | 379.4 | 13.3 | % | $ | (18.3) | (0.6) | % | ||||||||||||||||||||||||||||||
Cost of sales | 2,457.8 | 2,205.5 | 2,256.2 | (252.3) | (11.4) | % | 50.7 | 2.2 | % | |||||||||||||||||||||||||||||||||||
Gross margin | 784.3 | 657.2 | 624.8 | 127.1 | 19.3 | % | 32.4 | 5.2 | % | |||||||||||||||||||||||||||||||||||
Selling and administrative expense | 595.0 | 500.4 | 446.2 | (94.6) | (18.9) | % | (54.2) | (12.1) | % | |||||||||||||||||||||||||||||||||||
Operating income | 189.3 | 156.8 | 178.6 | 32.5 | 20.7 | % | (21.8) | (12.2) | % | |||||||||||||||||||||||||||||||||||
Interest expense, net | (74.6) | (59.5) | (62.8) | (15.1) | (25.4) | % | 3.3 | 5.3 | % | |||||||||||||||||||||||||||||||||||
Debt extinguishment costs | — | — | (1.1) | — | nm | 1.1 | nm | |||||||||||||||||||||||||||||||||||||
Other income (expense), net | 24.3 | 12.1 | (12.9) | 12.2 | nm | 25.0 | nm | |||||||||||||||||||||||||||||||||||||
Income from continuing operations before income taxes | 139.0 | 109.4 | 101.8 | 29.6 | 27.1 | % | 7.6 | 7.5 | % | |||||||||||||||||||||||||||||||||||
Income tax expense | (5.2) | (33.7) | (14.4) | 28.5 | nm | (19.3) | nm | |||||||||||||||||||||||||||||||||||||
Net income from continuing operations | $ | 133.8 | $ | 75.7 | $ | 87.4 | $ | 58.1 | 76.8 | % | $ | (11.7) | (13.4) | % | ||||||||||||||||||||||||||||||
(Loss) income from discontinued operations, net of income taxes | (0.4) | 513.1 | 72.1 | (513.5) | nm | 441.0 | nm | |||||||||||||||||||||||||||||||||||||
Net income | 133.4 | 588.8 | 159.5 | (455.4) | nm | 429.3 | nm | |||||||||||||||||||||||||||||||||||||
Net (income) loss attributable to noncontrolling interests | (1.8) | (0.2) | 0.3 | (1.6) | nm | (0.5) | nm | |||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Avient common shareholders | $ | 131.6 | $ | 588.6 | $ | 159.8 | $ | (457.0) | nm | $ | 428.8 | nm | ||||||||||||||||||||||||||||||||
Earnings (loss) per share attributable to Avient common shareholders - basic: | ||||||||||||||||||||||||||||||||||||||||||||
Continuing operations | $ | 1.47 | $ | 0.98 | $ | 1.10 | ||||||||||||||||||||||||||||||||||||||
Discontinued operations | (0.01) | 6.64 | 0.91 | |||||||||||||||||||||||||||||||||||||||||
Total | $ | 1.46 | $ | 7.62 | $ | 2.01 | ||||||||||||||||||||||||||||||||||||||
Earnings (loss) per share attributable to Avient common shareholders - diluted: | ||||||||||||||||||||||||||||||||||||||||||||
Continuing operations | $ | 1.46 | $ | 0.97 | $ | 1.09 | ||||||||||||||||||||||||||||||||||||||
Discontinued operations | (0.01) | 6.61 | 0.90 | |||||||||||||||||||||||||||||||||||||||||
Total | $ | 1.45 | $ | 7.58 | $ | 1.99 | ||||||||||||||||||||||||||||||||||||||
Twelve Months Ended December 31, | ||||||||||||||||||||
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Federal statutory income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||
Tax on GILTI and FDII | 3.1 | (0.1) | 2.9 | |||||||||||||||||
International tax on certain current and prior year earnings | 2.0 | 1.6 | 9.4 | |||||||||||||||||
Net impact of non-deductible acquisition earnouts and transaction cost | 1.8 | 2.8 | 0.2 | |||||||||||||||||
Tax on one-time gain from sale of other assets | — | 6.0 | — | |||||||||||||||||
U.S. tax reform | — | 0.2 | (3.3) | |||||||||||||||||
Research and development credit | (2.1) | (2.8) | (0.8) | |||||||||||||||||
Domestic production activities deduction | — | — | (1.1) | |||||||||||||||||
One-time U.S. tax benefit from internal reorganization of international subsidiaries | (13.1) | — | — | |||||||||||||||||
State and local tax, net | (3.4) | 4.2 | 2.3 | |||||||||||||||||
International tax rate differential | (2.7) | (8.9) | (12.1) | |||||||||||||||||
International permanent items | (5.2) | 7.5 | (1.6) | |||||||||||||||||
Net impact of uncertain tax positions | 1.0 | (2.4) | (0.6) | |||||||||||||||||
Changes in valuation allowances | 0.5 | 1.7 | (3.4) | |||||||||||||||||
Other | 0.8 | — | 1.2 | |||||||||||||||||
Effective income tax rate | 3.7 | % | 30.8 | % | 14.1 | % |
2020 versus 2019
|
2019 versus 2018
|
|||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | 2020 | 2019 | 2018 | Change | % Change | Change | % Change | |||||||||||||||||||||||||||||||||||||
Sales: | ||||||||||||||||||||||||||||||||||||||||||||
Color, Additives and Inks | $ | 1,502.9 | $ | 1,003.8 | $ | 1,046.5 | $ | 499.1 | 49.7 | % | $ | (42.7) | (4.1) | % | ||||||||||||||||||||||||||||||
Specialty Engineered Materials | 708.8 | 745.7 | 645.8 | (36.9) | (4.9) | % | 99.9 | 15.5 | % | |||||||||||||||||||||||||||||||||||
Distribution | 1,110.3 | 1,192.2 | 1,265.4 | (81.9) | (6.9) | % | (73.2) | (5.8) | % | |||||||||||||||||||||||||||||||||||
Corporate and eliminations | (79.9) | (79.0) | (76.7) | (0.9) | (1.1) | % | (2.3) | (3.0) | % | |||||||||||||||||||||||||||||||||||
Sales | $ | 3,242.1 | $ | 2,862.7 | $ | 2,881.0 | $ | 379.4 | 13.3 | % | $ | (18.3) | (0.6) | % | ||||||||||||||||||||||||||||||
Operating income: | ||||||||||||||||||||||||||||||||||||||||||||
Color, Additives and Inks | $ | 180.8 | $ | 147.4 | $ | 158.5 | $ | 33.4 | 22.7 | % | $ | (11.1) | (7.0) | % | ||||||||||||||||||||||||||||||
Specialty Engineered Materials | 94.4 | 83.7 | 72.3 | 10.7 | 12.8 | % | 11.4 | 15.8 | % | |||||||||||||||||||||||||||||||||||
Distribution | 69.5 | 75.4 | 71.5 | (5.9) | (7.8) | % | 3.9 | 5.5 | % | |||||||||||||||||||||||||||||||||||
Corporate and eliminations | (155.4) | (149.7) | (123.7) | (5.7) | (3.8) | % | (26.0) | (21.0) | % | |||||||||||||||||||||||||||||||||||
Operating income | $ | 189.3 | $ | 156.8 | $ | 178.6 | $ | 32.5 | 20.7 | % | $ | (21.8) | (12.2) | % | ||||||||||||||||||||||||||||||
Operating income as a percentage of sales: | ||||||||||||||||||||||||||||||||||||||||||||
Color, Additives and Inks | 12.0 | % | 14.7 | % | 15.1 | % | (2.7) | % | points | (0.4) | % | points | ||||||||||||||||||||||||||||||||
Specialty Engineered Materials | 13.3 | % | 11.2 | % | 11.2 | % | 2.1 | % | points | — | % | points | ||||||||||||||||||||||||||||||||
Distribution | 6.3 | % | 6.3 | % | 5.7 | % | — | % | points | 0.6 | % | points | ||||||||||||||||||||||||||||||||
Total | 5.8 | % | 5.5 | % | 6.2 | % | 0.3 | % | points | (0.7) | % | points | ||||||||||||||||||||||||||||||||
(In millions) | |||||
Cash and cash equivalents | $ | 649.5 | |||
Revolving credit availability | 279.9 | ||||
Liquidity | $ | 929.4 |
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Cash provided by (used by): | ||||||||||||||||||||
Operating Activities | $ | 221.6 | $ | 300.8 | $ | 253.7 | ||||||||||||||
Investing Activities | (1,431.6) | 611.9 | (170.3) | |||||||||||||||||
Financing Activities | 982.0 | (218.3) | (148.1) | |||||||||||||||||
Effect of exchange rate on cash | 12.8 | (0.6) | (8.0) | |||||||||||||||||
Net increase (decrease) in cash and cash equivalents | $ | (215.2) | $ | 693.8 | $ | (72.7) |
(In millions) | December 31, 2020 | December 31, 2019 | |||||||||
Senior secured revolving credit facility due 2022 | $ | — | $ | — | |||||||
5.25% senior notes due 2023 | 597.5 | 596.3 | |||||||||
5.75% senior notes due 2025 | 641.2 | — | |||||||||
Senior secured term loan due 2026 | 610.0 | 614.7 | |||||||||
Other Debt | 23.9 | 18.3 | |||||||||
Total Debt | $ | 1,872.6 | $ | 1,229.3 | |||||||
Less short-term and current portion of long-term debt | 18.6 | 18.4 | |||||||||
Total long-term debt, net of current portion | $ | 1,854.0 | $ | 1,210.9 | |||||||
Payment Due by Period | ||||||||||||||||||||||||||||||||
(In millions) | Total | 2021 | 2022 & 2023 | 2024 & 2025 | Thereafter | |||||||||||||||||||||||||||
Total debt (1) | $ | 1,891.9 | $ | 18.6 | $ | 617.2 | $ | 667.3 | $ | 588.8 | ||||||||||||||||||||||
Operating leases | 91.1 | 28.0 | 36.4 | 13.4 | 13.3 | |||||||||||||||||||||||||||
Interest on long-term debt obligations (2) | 375.4 | 90.4 | 172.7 | 109.2 | 3.1 | |||||||||||||||||||||||||||
Pension and post-retirement obligations (3) | 83.2 | 8.9 | 16.9 | 16.7 | 40.7 | |||||||||||||||||||||||||||
Purchase obligations (4) | 52.4 | 33.9 | 17.4 | 1.1 | — | |||||||||||||||||||||||||||
Total | $ | 2,494.0 | $ | 179.8 | $ | 860.6 | $ | 807.7 | $ | 645.9 |
Description | Judgments and Uncertainties |
Effect if Actual Results
Differ from Assumptions |
||||||||||||
Environmental Liabilities | ||||||||||||||
• Based upon our estimates, we had an undiscounted accrual of $119.7 million at December 31, 2020 for probable future environmental expenditures. Any such provision is recognized using the Company's best estimate of the amount of loss incurred, or at the lower end of an estimated range, when a single best estimate is not determinable.
• With respect to the former Goodrich Corporation Calvert City site, the United States Environmental Protection Agency (USEPA) issued its Record of Decision (ROD) in September 2018, selecting a remedy consistent with our accrual assumptions. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial design. In October 2019, the USEPA sent a Special Notice Letter to Avient, Westlake Vinyls, and Goodrich Corporation, inviting negotiation of a Consent Decree to perform the remedial actions at the site. In 2020, the three companies, USEPA, and the US Department of Justice signed the agreed Consent Decree, which is currently under Federal Court review.
• Franklin-Burlington, a subsidiary of Avient, is listed as a cooperating party along with approximately 70 other companies. The cooperating parties are working with the EPA on the lower Passaic River Study Area. Based on currently available information as of December 31, 2020, we have not identified evidence that Franklin-Burlington contributed materially to the contamination into the lower Passaic River and that the best estimate of any liability that may be assigned to Franklin-Burlington will not be material to the consolidated financial statements.
• In some cases, the Company recovers a portion of the costs relating to these obligations from insurers or other third parties; however, the Company records such amounts only when they are collected.
|
• This accrual represents our best estimate of the remaining probable costs based upon information and technology currently available. Depending upon the results of future testing, the ultimate remediation alternatives undertaken, changes in regulations, new information, newly discovered conditions and other factors, it is reasonably possible that we could incur additional costs in excess of the amount accrued. However, such additional costs, if any, cannot currently be estimated. Our estimate of this liability may be revised as new regulations or technologies are developed or additional information is obtained.
|
• If further developments or resolution of these matters are not consistent with our assumptions and judgments, we may need to recognize a significant adjustment in a future period.
• As we progress through certain benchmarks such as completion of the remedial investigation and feasibility study, issuance of a record of decision and remedial design, additional information will become available that may require an adjustment to our existing reserves.
|
Description | Judgments and Uncertainties |
Effect if Actual Results
Differ from Assumptions |
||||||||||||
Pension and Other Post-retirement Plans | ||||||||||||||
• We account for our defined benefit pension plans and other post-retirement plans in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Update (ASC) Topic 715, Compensation — Retirement Benefits. We immediately recognize actuarial gains and losses in our operating results in the year in which the gains or losses occur. In 2020, we recognized a $17.2 million benefit as a result of the recognition of these actuarial gains, which favorably impacted net income (loss), comprehensive income (loss) and the funded status of our pension plans, primarily the result of actual asset returns that were higher than our assumed returns and mortality assumptions. Partially offsetting these gains was a decrease in our discount rate.
|
• Asset returns and interest rates significantly affect the value of future assets and liabilities of our pension and post-retirement plans and therefore the funded status of our plans. It is difficult to predict these factors due to the volatility of market conditions.
• To develop our discount rate, we consider the yields of high-quality corporate bonds with maturities that correspond to the timing of our benefit obligations, referred to as the bond matching approach.
• To develop our expected long-term return on plan assets, we consider historical and forward looking long-term asset returns and the expected investment portfolio mix of plan assets. The weighted-average expected long-term rate of return on plan assets was 5.05% for 2020, 5.68% for 2019 and 5.09% for 2018.
• Life expectancy is a significant assumption that impacts our pension and other post-retirement benefits obligation. During 2020, we adopted the MP-2020 mortality improvement scale which was issued by the Society of Actuaries in October 2020.
|
• The weighted average discount rates used to value our pension liabilities as of December 31, 2020 and 2019 were 3.19% and 4.11%, respectively, post-retirement liabilities were 3.06% and 3.98%, respectively. As of December 31, 2020, an increase/decrease in the discount rate of 50 basis points, holding all other assumptions constant, would have increased or decreased pre-tax income and the related pension and post-retirement liability by approximately $19.4 million. An increase/decrease in the discount rate of 50 basis points as of December 31, 2020 would result in a change of approximately $1.3 million in the 2021 net periodic benefit cost.
• The expected long-term return on plan assets utilized as of January 1, 2020 and 2019 was 5.05% and 5.68%, respectively. An increase/decrease in our expected long-term return on plan assets of 50 basis points as of December 31, 2020, would result in a change of approximately $2.2 million to 2021 net periodic benefit cost.
|
||||||||||||
Income Taxes | ||||||||||||||
• We account for income taxes using the asset and liability method under ASC Topic 740. Under the asset and liability method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In addition, deferred tax assets are also recorded with respect to net operating losses and other tax attribute carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. Valuation allowances are established when realization of the benefit of deferred tax assets is not deemed to be more likely than not. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
• We recognize net tax benefits under the recognition and measurement criteria of ASC Topic 740, Income Taxes, which prescribes requirements and other guidance for financial statement recognition and measurement of positions taken or expected to be taken on tax returns. We record interest and penalties related to uncertain tax positions as a component of income tax expense.
|
• The ultimate recovery of certain of our deferred tax assets is dependent on the amount and timing of taxable income that we will ultimately generate in the future and other factors such as the interpretation of tax laws. We have provided valuation allowances as of December 31, 2020, aggregating to $20.7 million primarily against certain international and state net operating loss carryforwards based on our current assessment of future operating results and other factors. At December 31, 2020, the gross liability for unrecognized income tax benefits, including interest and penalties, totaled $10.6 million.
• Undistributed and indefinitely reinvested earnings for certain consolidated non-U.S. subsidiaries were approximately $456 million as of December 31, 2020. No tax provision was made on these earnings as APB 23 provides guidance that U.S. companies do not need to recognize tax effects on international earnings that are indefinitely reinvested. Additionally, no deferred income taxes were recorded on taxable outside basis differences as it was not practicable to determine the tax provision impact.
|
• Although management believes that the estimates and judgments discussed herein are reasonable, actual results could differ, which could result in income tax expense or benefits that could be material.
|
Description | Judgments and Uncertainties |
Effect if Actual Results
Differ from Assumptions |
||||||||||||
Goodwill | ||||||||||||||
• Goodwill represents the excess of the purchase price over the fair value of the net assets of acquired companies. We follow the guidance in ASC 350, Intangibles — Goodwill and Other, including subsequent updates, and test goodwill for impairment at least annually, absent a triggering event that would warrant an impairment assessment. On an ongoing basis, absent any impairment indicators, we perform our goodwill impairment testing as of the first day of October of each year.
|
• We have identified our reporting units at the operating segment level, or in most cases, one level below the operating segment level. Goodwill is allocated to the reporting units based on the estimated fair value at the date of acquisition.
• We estimated fair value using the best information available to us, including market information and discounted cash flow projections using the income approach.
• The income approach requires us to make assumptions and estimates regarding projected economic and market conditions, growth rates, operating margins and cash expenditures. Sensitivity analyses were performed around these assumptions in order to assess the reasonableness of the assumptions and the resulting estimated fair values.
• Goodwill related to our acquisition of Clariant MB as of December 31, 2020 was determined on a preliminary basis. The final valuation of the acquisition and related goodwill balance will be completed in 2021, and actual results could differ from our estimates.
|
• If actual results are not consistent with our assumptions and estimates, we may be exposed to goodwill impairment charges.
• The fair value of the reporting unit is based on a number of subjective factors including: (a) appropriate consideration of valuation approaches, (b) the consideration of our business outlook and (c) weighted average cost of capital (discount rate), growth rates and market multiples for our estimated cash flows.
• Based on our 2020 annual impairment test performed on October 1st, we determined there were no reporting units considered to be at risk of impairment. We believe that the current assumptions and estimates are reasonable, supportable and appropriate. The business could be impacted by unforeseen changes in market factors or opportunities, which could impact our existing assumptions used in our impairment test. As such, there can be no assurance that these estimates and assumptions made for the purposes of the goodwill impairment test will prove to be accurate predictions of future performance.
|
Indefinite-lived Intangible Assets | ||||||||||||||
• Indefinite-lived intangible assets represent trade names associated with acquired companies.
|
• We estimate the fair value of trade names using a “relief from royalty payments” approach. This approach involves two steps: (1) estimating reasonable royalty rate for the trade name and (2) applying this royalty rate to a net sales stream and discounting the resulting cash flows to determine fair value. Fair value is then compared with the carrying value of the trade name.
|
• If actual results are not consistent with our assumptions and estimates, we may be exposed to impairment charges related to our indefinite lived trade name
• Based on our 2020 annual impairment test, no trade names were considered at risk.
|
||||||||||||
Page | |||||
Management’s Report | |||||
Reports of Independent Registered Public Accounting Firm | |||||
Consolidated Financial Statements: | |||||
Consolidated Statements of Income | |||||
Consolidated Statements of Comprehensive Income | |||||
Consolidated Balance Sheets | |||||
Consolidated Statements of Cash Flows | |||||
Consolidated Statements of Shareholders’ Equity | |||||
Notes to Consolidated Financial Statements |
/s/ ROBERT M. PATTERSON | /s/ JAMIE A. BEGGS | |||||||
Robert M. Patterson | Jamie A. Beggs | |||||||
Chairman, President and Chief Executive Officer | Senior Vice President and Chief Financial Officer | |||||||
Environmental Accrued Liabilities | ||||||||
Description of the Matter
|
As described in Note 12 to the consolidated financial statements, the environmental accrued liability as of December 31, 2020 is approximately $119.7 million and is comprised primarily of the cost estimate for the Calvert City location of $106.4 million. The Company records an accrual for probable future environmental remediation projects on an undiscounted basis which represents management’s best estimate of probable future costs based upon currently available information and technology and management’s view of the most likely remedy. | |||||||
Auditing the determination of the accrual involved a high degree of subjectivity as estimates underlying the determination of the accrual were based on assumptions unique to the affected site and subject to various laws and regulations governing the protection of the applicable environment. Actual costs incurred in future periods could differ from amounts estimated and future changes to environmental laws and regulations could increase the extent of remediation work required, therefore the calculation is complicated due to uncertainty in determining the probable future costs and the extent of the remediation efforts.
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s process to establish the environmental accrued liability, including management’s review and evaluation of the information included in the Calvert City Record of Decision and the Administrative Settlement Agreement and Order on Consent issued by the United States Environmental Protection Agency (USEPA). For example, we tested controls over management’s review of the estimation and the significant assumptions used to develop future cost estimates. We also tested management’s controls to validate that the data used in the accrual estimate was complete and accurate.
|
|||||||
With the assistance of our specialist, we tested the balance of the environmental accrued liability and the disclosure of the expected cost to remediate. Our audit procedures included, among others, making inquiries of internal general counsel, obtaining internal general counsel’s representation and external communications used in determining the environmental accrued liability. This included an evaluation of externally available information and a comparison of management’s cost estimates to the estimates published in the Record of Decision by the USEPA. We tested the significant assumptions used by management by comparing those assumptions to accepted industry practice and information included in the Record of Decision issued by the USEPA. We examined historical costs for recurring items and compared those amounts to future projections for similar costs.
|
||||||||
Quantitative Impairment Assessment of Goodwill | ||||||||
Description of the Matter
|
At December 31, 2020, the Company’s goodwill was approximately $1,294.9 million. As discussed in Note 1 to the consolidated financial statements, goodwill is tested for impairment at least annually at the reporting unit level or at an interim date if potential impairment indicators are present. The Company’s goodwill is initially assigned to its reporting units as of the acquisition date. Goodwill is tested for impairment, quantitatively or qualitatively, at the reporting unit level. As it relates to the quantitative approach, the Company uses an income approach to estimate the fair value of the reporting units using a combination of internal forecasts, external market information and discounted cash flow projections.
|
|||||||
Auditing the impairment assessment of the quantitative goodwill assessment for a certain reporting unit is complex as the income approach requires the Company to make assumptions and estimates regarding projected economic and market conditions, growth rates, operating margins and cash expenditures. The fair value of the reporting unit is based on a number of subjective factors including; (a) appropriate consideration of valuation approaches, (b) the consideration of the Company’s business outlook, and (c) weighted average cost of capital (discount rate), annual and terminal growth rates.
|
||||||||
How We Addressed the Matter in Our Audit |
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the quantitative impairment assessment of goodwill, including controls over management’s review of the significant assumptions described above.
|
|||||||
To test the estimated fair value of the Company’s reporting units, we performed audit procedures that included, among others, assessing methodologies and testing the significant assumptions discussed above and the underlying data used by the Company in its analyses. We compared the significant assumptions used by management to current industry and economic trends. We assessed the historical accuracy of management’s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting units that would result from changes in the assumptions. We also utilized our specialist to assist in the review of the methodology, weighted average cost of capital, terminal growth rates used by the Company and the reconciliation of the aggregate estimated fair value of the reporting units to the market capitalization of the Company.
|
Accounting for the Clariant Masterbatch Business Combination
|
||||||||
Description of the Matter |
As discussed in Note 2 to the consolidated financial statements, on July 1, 2020 the Company completed its acquisition of the equity interests in the global masterbatch business of Clariant AG and the masterbatch assets in India of Clariant Chemicals (India) Limited. The business and assets are collectively referred to as Clariant MB and the acquisitions are collectively referred to as the Clariant MB Acquisition. Total consideration paid by the Company to complete the Clariant MB Acquisition was approximately $1.4 billion, net of cash and debt. The acquisition is being accounted for under the acquisition method of accounting.
|
|||||||
Auditing the Company’s accounting for the preliminary allocation of the purchase price
to the identifiable assets and liabilities for the Clariant MB Acquisition was complex due to the significant estimation in determining the preliminary fair value of identifiable intangible assets, which principally consisted of customer relationships and developed technology. The Company used the relief from royalty and multi-period excess earnings method to determine the fair value of developed technology and customer relationships, respectively. The purchase price allocation, including the fair value estimates of the identifiable intangible assets, were recorded on a preliminary basis. The high degree of subjectivity was primarily due to the sensitivity of the respective fair values to underlying assumptions about the future performance of the acquired business. The significant assumptions used to estimate the value of the intangible assets included discount rates and certain assumptions that form the basis of the forecasted results including revenue growth rates, profitability, and royalty rates.
|
||||||||
How We Addressed the Matter in Our Audit |
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the determination of the preliminary fair value of the identifiable intangible assets. This included testing controls over management’s review of the fair value methodologies and significant assumptions described above.
|
|||||||
To test the preliminary estimated fair values of the acquired intangible assets, our audit procedures included, among others, assessing methodologies and testing the significant assumptions discussed above and the underlying data used by the Company. We compared the significant assumptions used by management to current industry and economic trends. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value that would result from changes in the assumptions. We utilized our specialist in assessing the methodologies applied and evaluating significant assumptions. Furthermore, we assessed the appropriateness of the disclosures in the consolidated financial statements regarding the acquisition.
|
Year Ended December 31, | ||||||||||||||||||||
(In millions, except per share data) |
2020
|
2019
|
2018
|
|||||||||||||||||
Sales | $ | 3,242.1 | $ | 2,862.7 | $ | 2,881.0 | ||||||||||||||
Cost of sales | 2,457.8 | 2,205.5 | 2,256.2 | |||||||||||||||||
Gross margin | 784.3 | 657.2 | 624.8 | |||||||||||||||||
Selling and administrative expense | 595.0 | 500.4 | 446.2 | |||||||||||||||||
Operating income | 189.3 | 156.8 | 178.6 | |||||||||||||||||
Interest expense, net | (74.6) | (59.5) | (62.8) | |||||||||||||||||
Debt extinguishment costs | — | — | (1.1) | |||||||||||||||||
Other income (expense), net | 24.3 | 12.1 | (12.9) | |||||||||||||||||
Income from continuing operations before income taxes | 139.0 | 109.4 | 101.8 | |||||||||||||||||
Income tax expense | (5.2) | (33.7) | (14.4) | |||||||||||||||||
Net income from continuing operations | 133.8 | 75.7 | 87.4 | |||||||||||||||||
Income (loss) from discontinued operations, net of income taxes | (0.4) | 513.1 | 72.1 | |||||||||||||||||
Net income | 133.4 | 588.8 | 159.5 | |||||||||||||||||
Net (income) loss attributable to noncontrolling interests | (1.8) | (0.2) | 0.3 | |||||||||||||||||
Net income attributable to Avient common shareholders | $ | 131.6 | $ | 588.6 | $ | 159.8 | ||||||||||||||
Earnings per share attributable to Avient common shareholders - Basic: | ||||||||||||||||||||
Continuing operations | $ | 1.47 | $ | 0.98 | $ | 1.10 | ||||||||||||||
Discontinued operations | (0.01) | 6.64 | 0.91 | |||||||||||||||||
Total | $ | 1.46 | $ | 7.62 | $ | 2.01 | ||||||||||||||
Earnings per share attributable to Avient common shareholders - Diluted: | ||||||||||||||||||||
Continuing operations | $ | 1.46 | $ | 0.97 | $ | 1.09 | ||||||||||||||
Discontinued operations | (0.01) | 6.61 | 0.90 | |||||||||||||||||
Total | $ | 1.45 | $ | 7.58 | $ | 1.99 | ||||||||||||||
Weighted-average shares used to compute earnings per common share: | ||||||||||||||||||||
Basic | 90.1 | 77.2 | 79.7 | |||||||||||||||||
Plus dilutive impact of share-based compensation | 0.5 | 0.5 | 0.7 | |||||||||||||||||
Diluted | 90.6 | 77.7 | 80.4 | |||||||||||||||||
Anti-dilutive shares not included in diluted common shares outstanding | 0.8 | 0.6 | — | |||||||||||||||||
Cash dividends declared per share of common stock | $ | 0.820 | $ | 0.788 | $ | 0.720 |
Year Ended December 31, | |||||||||||||||||
(In millions) |
2020
|
2019
|
2018
|
||||||||||||||
Net income | $ | 133.4 | $ | 588.8 | $ | 159.5 | |||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||
Translation adjustments and related hedging instruments | 110.6 | 2.2 | (27.6) | ||||||||||||||
Cash flow hedges | (1.6) | (2.5) | (1.3) | ||||||||||||||
Other | — | — | (0.4) | ||||||||||||||
Total other comprehensive income (loss) | 109.0 | (0.3) | (29.3) | ||||||||||||||
Total comprehensive income | 242.4 | 588.5 | 130.2 | ||||||||||||||
Comprehensive (income) loss attributable to noncontrolling interests | (1.8) | (0.2) | 0.3 | ||||||||||||||
Comprehensive income attributable to Avient common shareholders | $ | 240.6 | $ | 588.3 | $ | 130.5 |
Year Ended December 31, | |||||||||||
(In millions, except par value per share) |
2020
|
2019
|
|||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 649.5 | $ | 864.7 | |||||||
Accounts receivable, net | 516.6 | 330.0 | |||||||||
Inventories, net | 327.5 | 260.9 | |||||||||
Other current assets | 108.5 | 57.7 | |||||||||
Total current assets | 1,602.1 | 1,513.3 | |||||||||
Property, net | 694.9 | 407.4 | |||||||||
Goodwill | 1,308.1 | 685.7 | |||||||||
Intangible assets, net | 1,008.5 | 469.3 | |||||||||
Operating lease assets, net | 80.9 | 63.8 | |||||||||
Other non-current assets | 176.0 | 133.8 | |||||||||
Total assets | $ | 4,870.5 | $ | 3,273.3 | |||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Short-term and current portion of long-term debt | $ | 18.6 | $ | 18.4 | |||||||
Accounts payable | 471.7 | 287.7 | |||||||||
Current operating lease obligations | 25.1 | 21.0 | |||||||||
Accrued expenses and other current liabilities | 285.6 | 375.4 | |||||||||
Total current liabilities | 801.0 | 702.5 | |||||||||
Non-current liabilities: | |||||||||||
Long-term debt | 1,854.0 | 1,210.9 | |||||||||
Pension and other post-retirement benefits | 115.0 | 56.6 | |||||||||
Deferred income taxes | 140.0 | 63.5 | |||||||||
Non-current operating lease obligations | 56.0 | 42.8 | |||||||||
Other non-current liabilities | 192.8 | 144.3 | |||||||||
Total non-current liabilities | 2,357.8 | 1,518.1 | |||||||||
SHAREHOLDERS' EQUITY | |||||||||||
Common Shares, $0.01 par, 400.0 shares authorized, 122.2 shares issued
|
1.2 | 1.2 | |||||||||
Additional paid-in capital | 1,513.3 | 1,175.2 | |||||||||
Retained earnings | 1,057.4 | 1,001.2 | |||||||||
Common shares held in treasury, at cost, 30.9 shares in 2020 and 45.3 shares in 2019
|
(901.2) | (1,043.1) | |||||||||
Accumulated other comprehensive income (loss) | 26.4 | (82.6) | |||||||||
Avient shareholders’ equity | 1,697.1 | 1,051.9 | |||||||||
Noncontrolling interest | 14.6 | 0.8 | |||||||||
Total equity | 1,711.7 | 1,052.7 | |||||||||
Total liabilities and equity | $ | 4,870.5 | $ | 3,273.3 |
Year Ended December 31, | |||||||||||||||||
(In millions) |
2020
|
2019
|
2018
|
||||||||||||||
Operating activities | |||||||||||||||||
Net income | $ | 133.4 | $ | 588.8 | $ | 159.5 | |||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Gain on sale of business, net of tax | — | (457.7) | — | ||||||||||||||
Depreciation and amortization | 111.8 | 87.5 | 88.5 | ||||||||||||||
Accelerated depreciation and fixed asset charges associated with restructuring activities | 3.2 | — | 3.0 | ||||||||||||||
Deferred income tax benefit | (1.7) | (3.2) | (4.8) | ||||||||||||||
Debt extinguishment costs | — | — | 1.1 | ||||||||||||||
Share-based compensation expense | 11.3 | 11.6 | 10.9 | ||||||||||||||
Changes in assets and liabilities, net of the effect of acquisitions: | |||||||||||||||||
(Increase) decrease in accounts receivable | (4.6) | 29.7 | (11.3) | ||||||||||||||
Decrease (increase) in inventories | 40.2 | 40.2 | (10.6) | ||||||||||||||
Increase (decrease) in accounts payable | 78.4 | (22.7) | 7.9 | ||||||||||||||
Increase (decrease) in pension and other post-retirement benefits | 30.7 | (19.7) | 4.8 | ||||||||||||||
Increase in post-acquisition earnout liabilities | 1.0 | 36.4 | 0.7 | ||||||||||||||
(Decrease) increase in accrued expenses and other assets and liabilities - net | (2.0) | 9.9 | 4.0 | ||||||||||||||
Taxes paid on gain on sale of business | (142.0) | — | — | ||||||||||||||
Payment of post-acquisition date earnout liability | (38.1) | — | — | ||||||||||||||
Net cash provided by operating activities | 221.6 | 300.8 | 253.7 | ||||||||||||||
Investing activities | |||||||||||||||||
Capital expenditures | (63.7) | (81.7) | (76.0) | ||||||||||||||
Business acquisitions, net of cash acquired | (1,380.2) | (119.6) | (98.6) | ||||||||||||||
Net proceeds from divestiture | 7.1 | 761.8 | — | ||||||||||||||
Net proceeds from other assets | 5.2 | 51.4 | 4.3 | ||||||||||||||
Net cash (used) provided by investing activities | (1,431.6) | 611.9 | (170.3) | ||||||||||||||
Financing activities | |||||||||||||||||
Debt offering proceeds | 650.0 | — | — | ||||||||||||||
Borrowings under credit facilities | — | 963.4 | 1,152.9 | ||||||||||||||
Repayments under credit facilities | — | (1,083.9) | (1,090.3) | ||||||||||||||
Purchase of common shares for treasury | (22.4) | (26.9) | (123.0) | ||||||||||||||
Cash dividends paid | (71.3) | (60.3) | (56.1) | ||||||||||||||
Repayment of other debt | — | (1.8) | (16.4) | ||||||||||||||
Repayment of long-term debt | (7.8) | (6.5) | (6.5) | ||||||||||||||
Payments on withholding tax on share awards | (2.3) | (2.1) | (4.1) | ||||||||||||||
Debt financing costs | (9.5) | (0.2) | (4.6) | ||||||||||||||
Equity offering proceeds, net of underwriting discount and issuance costs | 496.1 | — | — | ||||||||||||||
Payment of acquisition date earnout liability | (50.8) | — | — | ||||||||||||||
Net cash provided (used) by financing activities | 982.0 | (218.3) | (148.1) | ||||||||||||||
Effect of exchange rate changes on cash | 12.8 | (0.6) | (8.0) | ||||||||||||||
Increase (decrease) in cash and cash equivalents | (215.2) | 693.8 | (72.7) | ||||||||||||||
Cash and cash equivalents at beginning of year | 864.7 | 170.9 | 243.6 | ||||||||||||||
Cash and cash equivalents at end of year | $ | 649.5 | $ | 864.7 | $ | 170.9 |
Common Shares | Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(In millions) |
Common
Shares |
Common
Shares Held in Treasury |
Common
Shares |
Additional
Paid-in Capital |
Retained Earnings |
Common
Shares Held in Treasury |
Accumulated
Other Comprehensive Income (Loss) |
Total Avient shareholders' equity | Non-controlling Interests | Total equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2018 | 122.2 | (41.3) | $ | 1.2 | $ | 1,161.5 | $ | 387.1 | $ | (898.3) | $ | (53.0) | $ | 598.5 | $ | 0.9 | $ | 599.4 | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | 159.8 | — | — | 159.8 | (0.3) | 159.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (29.3) | (29.3) | — | (29.3) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash dividends declared (1)
|
— | — | — | — | (57.5) | — | — | (57.5) | — | (57.5) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common shares | — | (3.4) | — | — | — | (123.0) | — | (123.0) | — | (123.0) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation and exercise of awards | — | 0.2 | — | 5.4 | — | 2.6 | — | 8.0 | — | 8.0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other (2)
|
— | — | — | — | (16.5) | — | — | (16.5) | — | (16.5) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2018 | 122.2 | (44.5) | $ | 1.2 | $ | 1,166.9 | $ | 472.9 | $ | (1,018.7) | $ | (82.3) | $ | 540.0 | $ | 0.6 | $ | 540.6 | ||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | 588.6 | — | — | 588.6 | 0.2 | 588.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (0.3) | (0.3) | — | (0.3) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash dividends declared (1)
|
— | — | — | — | (60.3) | — | — | (60.3) | — | (60.3) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common shares | — | (1.0) | — | — | — | (26.9) | — | (26.9) | — | (26.9) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation and exercise of awards | — | 0.2 | — | 8.3 | — | 2.5 | — | 10.8 | — | 10.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019 | 122.2 | (45.3) | $ | 1.2 | $ | 1,175.2 | $ | 1,001.2 | $ | (1,043.1) | $ | (82.6) | $ | 1,051.9 | $ | 0.8 | $ | 1,052.7 | ||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — | — | 131.6 | — | — | 131.6 | 1.8 | 133.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 109.0 | 109.0 | — | 109.0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Noncontrolling interest activity | — | — | — | — | — | — | — | — | (0.8) | (0.8) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash dividends declared (1)
|
— | — | — | — | (75.1) | — | — | (75.1) | — | (75.1) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common shares | — | (1.0) | — | — | — | (22.4) | — | (22.4) | — | (22.4) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Common shares equity offering | — | 15.3 | — | 334.8 | — | 161.3 | — | 496.1 | — | 496.1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation and exercise of awards | — | 0.1 | — | 3.3 | — | 3.0 | — | 6.3 | — | 6.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions/other | — | — | $ | — | $ | — | $ | (0.3) | $ | — | $ | — | $ | (0.3) | $ | 12.8 | $ | 12.5 | ||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 | 122.2 | (30.9) | $ | 1.2 | $ | 1,513.3 | $ | 1,057.4 | $ | (901.2) | $ | 26.4 | $ | 1,697.1 | $ | 14.6 | $ | 1,711.7 |
(1) Dividends declared per share were $0.820, $0.788, and $0.720 for the years ended December 31, 2020, 2019, and 2018, respectively.
|
||
(2) In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740), Intra-Entity Transfers of Assets Other than Inventory (ASU 2016-16), which requires companies to recognize the income tax effects of intercompany sales or transfers of assets, other than inventory, in the income statement as income tax expense or benefit in the period the sale or transfer occurs. We recognized an adjustment of $17.0 million to beginning retained earnings upon adoption of this standard on January 1, 2018 from transactions completed as of December 31, 2017.
|
(In millions) | Cumulative Translation Adjustment and Related Hedging Instruments | Pension and other post-retirement benefits | Cash Flow Hedges | Other | Total | |||||||||||||||||||||||||||
Balance at January 1, 2018 | $ | (58.6) | $ | 5.2 | $ | — | $ | 0.4 | $ | (53.0) | ||||||||||||||||||||||
Translation Adjustments | (25.6) | — | — | — | (25.6) | |||||||||||||||||||||||||||
Unrealized losses | (2.0) | — | (1.3) | — | (3.3) | |||||||||||||||||||||||||||
Other | — | — | — | (0.4) | (0.4) | |||||||||||||||||||||||||||
Balance at December 31, 2018 | (86.2) | 5.2 | (1.3) | — | (82.3) | |||||||||||||||||||||||||||
Translation Adjustments | (6.9) | — | — | — | (6.9) | |||||||||||||||||||||||||||
Unrealized losses | 9.1 | — | (2.5) | — | 6.6 | |||||||||||||||||||||||||||
Other | — | — | — | — | — | |||||||||||||||||||||||||||
Balance at December 31, 2019 | (84.0) | 5.2 | (3.8) | — | (82.6) | |||||||||||||||||||||||||||
Translation Adjustments | 110.6 | — | — | — | 110.6 | |||||||||||||||||||||||||||
Unrealized gains (losses) | — | — | (1.6) | — | (1.6) | |||||||||||||||||||||||||||
Other | — | — | — | — | — | |||||||||||||||||||||||||||
Balance at December 31, 2020 | $ | 26.6 | $ | 5.2 | $ | (5.4) | $ | — | $ | 26.4 | ||||||||||||||||||||||
July 1, 2020 | |||||
Cash and cash equivalents | $ | 145.1 | |||
Accounts receivable | 170.8 | ||||
Inventories | 99.0 | ||||
Other current assets | 56.9 | ||||
Property | 267.6 | ||||
Goodwill | 569.0 | ||||
Intangible assets: | |||||
Customer relationships | 221.9 | ||||
Trade names and trademarks | 32.0 | ||||
Patents, technology and other | 273.9 | ||||
Operating lease assets | 30.1 | ||||
Other long-term assets | 1.3 | ||||
Short term debt | (0.4) | ||||
Accounts payable | (92.7) | ||||
Current operating lease obligations | (2.8) | ||||
Accrued expenses and other current liabilities | (81.2) | ||||
Long-term debt | (6.7) | ||||
Non-current operating lease obligations | (25.8) | ||||
Deferred tax liabilities | (60.7) | ||||
Pension and other post-retirement benefits | (53.8) | ||||
Other long-term liabilities | (5.4) | ||||
Non-controlling interests | (12.8) | ||||
Total purchase price consideration | $ | 1,525.3 |
(Unaudited) | |||||||||||
Year Ended December 31, | |||||||||||
2020 | 2019 | ||||||||||
Sales | $ | 3,782.5 | $ | 3,981.3 | |||||||
Income from continuing operations before income taxes
|
204.2 | 98.9 |
(In millions) | 2020 | 2019 | 2018 | ||||||||||||||
Sales | $ | — | $ | 488.9 | $ | 652.4 | |||||||||||
Cost of sales | — | (390.1) | (532.3) | ||||||||||||||
Selling and administrative expense | (0.9) | (28.0) | (24.7) | ||||||||||||||
Gain on sale | — | 591.2 | (1.8) | ||||||||||||||
Pretax (loss) income of discontinued operations | (0.9) | 662.0 | 93.6 | ||||||||||||||
Income tax expense | 0.5 | (148.9) | (21.5) | ||||||||||||||
Income from discontinued operations, net of taxes | $ | (0.4) | $ | 513.1 | $ | 72.1 |
Year Ended December 31, | |||||||||||||||||
(In millions) | 2020 | 2019 | 2018 | ||||||||||||||
Depreciation and amortization | $ | — | $ | 9.4 | $ | 15.9 | |||||||||||
Capital Expenditures | — | 14.1 | 19.5 |
(In millions) | Specialty Engineered Materials | Color, Additives and Inks | Distribution | Total | |||||||||||||||||||
Balance at January 1, 2019 | $ | 188.9 | $ | 448.6 | $ | 1.6 | $ | 639.1 | |||||||||||||||
Acquisition of businesses | 47.9 | — | — | 47.9 | |||||||||||||||||||
Currency translation | (0.5) | (0.8) | — | (1.3) | |||||||||||||||||||
Balance at December 31, 2019 | 236.3 | 447.8 | 1.6 | 685.7 | |||||||||||||||||||
Acquisition of businesses | — | 569.0 | — | 569.0 | |||||||||||||||||||
Currency translation | 1.5 | 51.9 | — | 53.4 | |||||||||||||||||||
Balance at December 31, 2020 | $ | 237.8 | $ | 1,068.7 | $ | 1.6 | $ | 1,308.1 |
As of December 31, 2020 | ||||||||||||||||||||||||||
(In millions) | Acquisition Cost | Accumulated Amortization | Currency Translation | Net | ||||||||||||||||||||||
Customer relationships | $ | 508.7 | $ | (109.8) | $ | 23.8 | $ | 422.7 | ||||||||||||||||||
Patents, technology and other | 549.9 | (102.4) | 28.8 | 476.3 | ||||||||||||||||||||||
Indefinite-lived trade names | 109.5 | — | — | 109.5 | ||||||||||||||||||||||
Total | $ | 1,168.1 | $ | (212.2) | $ | 52.6 | $ | 1,008.5 |
As of December 31, 2019 | ||||||||||||||||||||||||||
(In millions) | Acquisition Cost | Accumulated Amortization | Currency Translation | Net | ||||||||||||||||||||||
Customer relationships | $ | 286.8 | $ | (89.1) | $ | (1.0) | $ | 196.7 | ||||||||||||||||||
Patents, technology and other | 244.0 | (79.6) | (1.3) | 163.1 | ||||||||||||||||||||||
Indefinite-lived trade names | 109.5 | — | — | 109.5 | ||||||||||||||||||||||
Total | $ | 640.3 | $ | (168.7) | $ | (2.3) | $ | 469.3 |
(In millions) | 2021 | 2022 | 2023 | 2024 | 2025 | ||||||||||||||||||||||||
Expected Amortization Expense | $ | 56.4 | $ | 54.3 | $ | 52.0 | $ | 51.9 | $ | 51.6 |
(in millions) | Year ended December 31, 2020 | |||||||
Cost of goods sold | $ | 4.2 | ||||||
Selling and administrative expenses | 15.4 | |||||||
Total employee separation and restructuring charges | $ | 19.6 |
As of December 31, 2020 (in millions) | Principal Amount | Unamortized discount and debt issuance cost | Net Debt | Weighted average interest rate | |||||||||||||||||||
Senior secured revolving credit facility due 2022 | $ | — | $ | — | $ | — | — | % | |||||||||||||||
5.25% senior notes due 2023
|
600.0 | 2.5 | 597.5 | 5.25 | % | ||||||||||||||||||
5.75% senior notes due 2025
|
650.0 | 8.8 | 641.2 | 5.75 | % | ||||||||||||||||||
Senior secured term loan due 2026 | 618.0 | 8.0 | 610.0 | 2.36 | % | ||||||||||||||||||
Other Debt | 23.9 | — | 23.9 | ||||||||||||||||||||
Total Debt | $ | 1,891.9 | $ | 19.3 | $ | 1,872.6 | |||||||||||||||||
Less short-term and current portion of long-term debt | 18.6 | — | 18.6 | ||||||||||||||||||||
Total long-term debt, net of current portion | $1,873.3 | $19.3 | $1,854.0 |
As of December 31, 2019 (in millions) | Principal Amount | Unamortized discount and debt issuance cost | Net Debt | Weighted average interest rate | |||||||||||||||||||
Senior secured revolving credit facility due 2022 | $ | — | $ | — | $ | — | 3.90 | % | |||||||||||||||
5.25%senior notes due 2023
|
600.0 | 3.7 | 596.3 | 5.25 | % | ||||||||||||||||||
Senior secured term loan due 2026 | 624.5 | 9.8 | 614.7 | 4.01 | % | ||||||||||||||||||
Other Debt | 18.3 | — | 18.3 | ||||||||||||||||||||
Total Debt | $ | 1,242.8 | $ | 13.5 | $ | 1,229.3 | |||||||||||||||||
Less short-term and current portion of long-term debt | 18.4 | — | 18.4 | ||||||||||||||||||||
Total long-term debt, net of current portion | $ | 1,224.4 | $ | 13.5 | $ | 1,210.9 |
(In millions) | ||||||||
2021 | $ | 18.6 | ||||||
2022 | 8.5 | |||||||
2023 | 608.7 | |||||||
2024 | 8.6 | |||||||
2025 | 658.7 | |||||||
Thereafter | 588.8 | |||||||
Aggregate maturities | $ | 1,891.9 | ||||||
Year Ended December 31, | ||||||||||||||
(In millions) | 2020 | 2019 | ||||||||||||
Cost of sales | $ | 11.9 | $ | 10.9 | ||||||||||
Selling and administrative expense | 19.1 | 13.1 | ||||||||||||
Total Operating lease cost | $ | 31.0 | $ | 24.0 |
Operating leases | ||||||||||||||
(in millions) | As of December 31, 2020 | |||||||||||||
2021 | $ | 28.0 | ||||||||||||
2022 | 21.4 | |||||||||||||
2023 | 15.0 | |||||||||||||
2024 | 8.7 | |||||||||||||
2025 | 4.7 | |||||||||||||
Thereafter | 13.3 | |||||||||||||
Total | $ | 91.1 | ||||||||||||
Less amount of lease payment representing interest | (10.0) | |||||||||||||
Total present value of lease payments | $ | 81.1 |
Operating leases | ||||||||||||||
(in millions) | As of December 31, 2019 | |||||||||||||
2020 | $ | 24.0 | ||||||||||||
2021 | 16.0 | |||||||||||||
2022 | 11.3 | |||||||||||||
2023 | 8.1 | |||||||||||||
2024 | 4.5 | |||||||||||||
Thereafter | 7.8 | |||||||||||||
Total | $ | 71.7 | ||||||||||||
Less amount of lease payment representing interest | (7.9) | |||||||||||||
Total present value of lease payments | $ | 63.8 |
December 31, | ||||||||||||||
(In millions) | 2020 | 2019 | ||||||||||||
Finished products | $ | 171.7 | $ | 157.6 | ||||||||||
Work in process | 16.6 | 8.0 | ||||||||||||
Raw materials and supplies | 139.2 | 95.3 | ||||||||||||
Inventories, net | $ | 327.5 | $ | 260.9 |
December 31, | ||||||||||||||
(In millions) | 2020 | 2019 | ||||||||||||
Land and land improvements
|
$ | 95.7 | $ | 32.8 | ||||||||||
Buildings
|
333.5 | 231.8 | ||||||||||||
Machinery and equipment | 948.2 | 748.9 | ||||||||||||
Property, gross | 1,377.4 | 1,013.5 | ||||||||||||
Less accumulated depreciation | (682.5) | (606.1) | ||||||||||||
Property, net | $ | 694.9 | $ | 407.4 |
Accrued expenses and
other current liabilities |
Other non-current liabilities | |||||||||||||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||||||||||||
(in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||
Employment costs | $ | 142.7 | $ | 68.6 | $ | 6.1 | $ | 20.5 | ||||||||||||||||||
Earnouts payable | — | 87.9 | — | — | ||||||||||||||||||||||
Environmental liabilities | 20.3 | 11.2 | 99.4 | 100.8 | ||||||||||||||||||||||
Accrued taxes | 49.0 | 165.4 | — | — | ||||||||||||||||||||||
Pension and other post-employment benefits | 6.7 | 4.8 | — | — | ||||||||||||||||||||||
Accrued interest | 14.1 | 10.0 | — | — | ||||||||||||||||||||||
Dividends payable | 19.4 | 15.6 | — | — | ||||||||||||||||||||||
Unrecognized tax benefits | 3.2 | 0.7 | 7.3 | 11.9 | ||||||||||||||||||||||
Net investment hedge | — | — | 48.4 | 5.1 | ||||||||||||||||||||||
Other | 30.2 | 11.2 | 31.6 | 6.0 | ||||||||||||||||||||||
Total | $ | 285.6 | $ | 375.4 | $ | 192.8 | $ | 144.3 |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||
(in millions) | 2020 |
2019
|
2020 | 2019 | ||||||||||||||||||||||
Change in benefit obligation: | ||||||||||||||||||||||||||
Projected benefit obligation - beginning of year | $ | 478.0 | $ | 462.7 | $ | 7.1 | $ | 7.4 | ||||||||||||||||||
Service cost | 3.0 | 0.5 | 0.1 | — | ||||||||||||||||||||||
Interest cost | 15.3 | 18.2 | 0.4 | 0.2 | ||||||||||||||||||||||
Actuarial loss | 24.5 | 34.0 | — | 0.1 | ||||||||||||||||||||||
Benefits paid | (40.9) | (36.9) | (0.7) | (0.8) | ||||||||||||||||||||||
Effect of settlement and/or curtailment | (23.0) | — | — | — | ||||||||||||||||||||||
Acquired benefit obligation | 137.3 | — | 11.3 | $ | — | |||||||||||||||||||||
Other | 7.8 | (0.5) | 0.1 | $ | 0.2 | |||||||||||||||||||||
Projected benefit obligation - end of year | 602.0 | 478.0 | 18.3 | 7.1 | ||||||||||||||||||||||
Projected salary increases | (8.8) | (1.9) | $ | — | $ | — | ||||||||||||||||||||
Accumulated benefit obligation | $ | 593.2 | $ | 476.1 | $ | 18.3 | $ | 7.1 | ||||||||||||||||||
Change in plan assets: | ||||||||||||||||||||||||||
Plan assets - beginning of year | $ | 469.1 | $ | 434.4 | $ | — | $ | — | ||||||||||||||||||
Actual return on plan assets | 60.5 | 67.4 | — | — | ||||||||||||||||||||||
Company contributions | 5.4 | 4.4 | 0.7 | 0.8 | ||||||||||||||||||||||
Benefits paid | (40.9) | (36.9) | (0.7) | (0.8) | ||||||||||||||||||||||
Effect of settlement and curtailment | (16.5) | — | — | — | ||||||||||||||||||||||
Acquired plan assets | 92.4 | — | $ | — | $ | — | ||||||||||||||||||||
Other | 3.6 | (0.2) | $ | — | $ | — | ||||||||||||||||||||
Plan assets - end of year | $ | 573.6 | $ | 469.1 | $ | — | $ | — | ||||||||||||||||||
Unfunded status at end of year | $ | (28.4) | $ | (8.9) | $ | (18.3) | $ | (7.1) |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||
(in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||
Non-current assets | $ | 75.0 | $ | 45.4 | $ | — | $ | — | ||||||||||||||||||
Accrued expenses and other liabilities | 5.4 | 4.0 | 1.3 | 0.8 | ||||||||||||||||||||||
Pension and other post-retirement benefits | 98.0 | 50.3 | 17.0 | 6.3 |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||
(in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||
Projected benefit obligation | $ | 149.5 | $ | 58.9 | $ | 18.3 | $ | 7.1 | ||||||||||||||||||
Accumulated benefit obligation | 122.8 | 57.0 | 18.3 | 7.1 | ||||||||||||||||||||||
Fair value of plan assets | 74.9 | 4.6 | — | — |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||||||||||||
Discount rate | 2.95 | % | 3.19 | % | 2.66 | % | 3.18 | % | ||||||||||||||||||
Assumed health care cost trend rates at December 31: | ||||||||||||||||||||||||||
Health care cost trend rate assumed for next year | N/A | N/A | 5.99 | % | 5.88 | % | ||||||||||||||||||||
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | N/A | N/A | 4.04 | % | 4.50 | % | ||||||||||||||||||||
Year that the rate reaches the ultimate trend rate | N/A | N/A | 2065 | 2027 |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||||||||||||||
(in millions) | 2020 | 2019 | 2018 | 2020 | 2019 | 2018 | ||||||||||||||||||||||||||||||||
Components of net periodic benefit costs (gains): | ||||||||||||||||||||||||||||||||||||||
Service Cost | $ | 3.0 | $ | 0.5 | $ | 0.6 | $ | 0.1 | $ | — | $ | — | ||||||||||||||||||||||||||
Interest Cost | 15.3 | 18.2 | 17.6 | 0.4 | 0.2 | 0.3 | ||||||||||||||||||||||||||||||||
Expected return on plan assets | (25.3) | (23.7) | (23.8) | — | — | — | ||||||||||||||||||||||||||||||||
Mark-to-market actuarial net losses (gains) | (10.8) | (9.7) | 16.2 | — | 0.1 | (0.6) | ||||||||||||||||||||||||||||||||
Curtailment | (6.4) | — | (0.1) | — | — | — | ||||||||||||||||||||||||||||||||
Net periodic cost (benefit) | $ | (24.2) | $ | (14.7) | $ | 10.5 | $ | 0.5 | $ | 0.3 | $ | (0.3) |
Pension Benefits | Health Care Benefits | |||||||||||||||||||||||||||||||||||||
2020 | 2019 | 2018 | 2020 | 2019 | 2018 | |||||||||||||||||||||||||||||||||
Discount rate* | 3.19 | % | 4.11 | % | 3.62 | % | 3.06 | % | 3.98 | % | 3.60 | % | ||||||||||||||||||||||||||
Expected long-term return on plan assets* | 5.05 | % | 5.68 | % | 5.09 | % | — | — | — | |||||||||||||||||||||||||||||
Assumed health care cost trend rates at December 31: | ||||||||||||||||||||||||||||||||||||||
Health care cost trend rate assumed for next year | N/A | N/A | N/A | 6.16 | % | 6.09 | % | 6.29 | % | |||||||||||||||||||||||||||||
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) | N/A | N/A | N/A | 4.14 | % | 4.50 | % | 4.50 | % | |||||||||||||||||||||||||||||
Year that the rate reaches the ultimate trend rate | N/A | N/A | N/A | 2054 | 2027 | 2027 |
Fair Value of Plan Assets at December 31, 2020 | ||||||||||||||||||||||||||
(In millions) |
Quoted
Prices in Active Markets (Level 1) |
Significant
Other Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Total Investments (at Fair Value) | ||||||||||||||||||||||
Asset category | ||||||||||||||||||||||||||
Cash | $ | 8.2 | $ | — | $ | — | $ | 8.2 | ||||||||||||||||||
Bonds and Notes | 53.4 | — | — | 53.4 | ||||||||||||||||||||||
Global Equity | 4.5 | — | — | 4.5 | ||||||||||||||||||||||
Other | — | 3.1 | 17.4 | 20.5 | ||||||||||||||||||||||
Total | $ | 66.1 | $ | 3.1 | $ | 17.4 | 86.6 | |||||||||||||||||||
Investments measured at NAV: | ||||||||||||||||||||||||||
Common collective funds: | ||||||||||||||||||||||||||
United States equity | 35.2 | |||||||||||||||||||||||||
International equity | 34.0 | |||||||||||||||||||||||||
Global equity | 383.8 | |||||||||||||||||||||||||
Fixed income | 16.3 | |||||||||||||||||||||||||
Balanced | 17.7 | |||||||||||||||||||||||||
Total common collective funds | $ | 487.0 | ||||||||||||||||||||||||
Total investments at fair value | $ | 573.6 |
Fair Value of Plan Assets at December 31, 2019 | ||||||||||||||||||||||||||
(In millions) |
Quoted
Prices in Active Markets (Level 1) |
Significant
Other Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Total Investments (at Fair Value) | ||||||||||||||||||||||
Asset category | ||||||||||||||||||||||||||
Cash | $ | 3.7 | $ | — | $ | — | $ | 3.7 | ||||||||||||||||||
Other | — | — | 4.6 | 4.6 | ||||||||||||||||||||||
Total | $ | 3.7 | $ | — | $ | 4.6 | 8.3 | |||||||||||||||||||
Investments at NAV | ||||||||||||||||||||||||||
Common collective funds | ||||||||||||||||||||||||||
United States equity | 31.7 | |||||||||||||||||||||||||
International equity | 31.9 | |||||||||||||||||||||||||
Global equity | 15.7 | |||||||||||||||||||||||||
Fixed income | 381.5 | |||||||||||||||||||||||||
Total common collective funds | $ | 460.8 | ||||||||||||||||||||||||
Total investments at fair value | $ | 469.1 |
(In millions) | Pension Benefits | Health Care benefits | ||||||||||||
2021 | $ | 47.5 | $ | 1.3 | ||||||||||
2022 | 42.5 | 1.3 | ||||||||||||
2023 | 42.5 | 1.3 | ||||||||||||
2024 | 40.9 | 1.3 | ||||||||||||
2025 | 39.8 | 1.3 | ||||||||||||
2026 through 2030 | 184.0 | 5.7 |
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Retirement savings match | $ | 9.9 | $ | 10.4 | $ | 10.1 | ||||||||||||||
Retirement savings contribution | 0.6 | — | — | |||||||||||||||||
Total contribution | $ | 10.5 | $ | 10.4 | $ | 10.1 |
(in millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Balance at beginning of the year | $ | 112.0 | $ | 111.9 | $ | 114.8 | ||||||||||||||
Environmental expenses | 20.4 | 10.2 | 23.1 | |||||||||||||||||
Net cash payments | (12.7) | (10.3) | (26.0) | |||||||||||||||||
Currency translation and other | — | 0.2 | — | |||||||||||||||||
Balance at the end of year | $ | 119.7 | $ | 112.0 | $ | 111.9 |
(In millions) |
2020
|
2019
|
2018
|
|||||||||||||||||
Domestic | $ | 19.6 | $ | 41.2 | $ | 4.1 | ||||||||||||||
International | 119.4 | 68.2 | 97.7 | |||||||||||||||||
Income from continuing operations, before income taxes
|
$ | 139.0 | $ | 109.4 | $ | 101.8 |
(In millions) |
2020
|
2019
|
2018
|
|||||||||||||||||
Current income tax expense (benefit): | ||||||||||||||||||||
Domestic | $ | (25.8) | $ | 24.8 | $ | (0.4) | ||||||||||||||
International | 32.7 | 21.9 | 22.0 | |||||||||||||||||
Total current income tax expense | $ | 6.9 | $ | 46.7 | $ | 21.6 | ||||||||||||||
Deferred income tax (benefit) expense: | ||||||||||||||||||||
Domestic | $ | 17.2 | $ | (12.5) | $ | 11.1 | ||||||||||||||
International | (18.9) | (0.5) | (18.3) | |||||||||||||||||
Total deferred income tax benefit | $ | (1.7) | $ | (13.0) | $ | (7.2) | ||||||||||||||
Total income tax expense | $ | 5.2 | $ | 33.7 | $ | 14.4 |
Twelve Months Ended December 31, | ||||||||||||||||||||||||||
2020
|
2019
|
2018
|
||||||||||||||||||||||||
Federal statutory income tax rate | 21.0 | % | 21.0 | % | 21.0 | % | ||||||||||||||||||||
International tax rate differential: | ||||||||||||||||||||||||||
Asia | 0.5 | 0.7 | 0.4 | |||||||||||||||||||||||
Europe | (4.4) | (10.3) | (11.6) | |||||||||||||||||||||||
North and South America | 1.2 | 0.7 | (0.9) | |||||||||||||||||||||||
Total international tax rate differential | (2.7) | (8.9) | (12.1) | |||||||||||||||||||||||
Tax on GILTI and FDII | 3.1 | (0.1) | 2.9 | |||||||||||||||||||||||
International tax on certain current and prior year earnings | 2.0 | 1.6 | 9.4 | |||||||||||||||||||||||
Net impact of non-deductible acquisition earnouts and transaction cost | 1.8 | 2.8 | 0.2 | |||||||||||||||||||||||
Tax on one-time gain from sale of other assets | — | 6.0 | — | |||||||||||||||||||||||
U.S. tax reform | — | 0.2 | (3.3) | |||||||||||||||||||||||
Research and development credit | (2.1) | (2.8) | (0.8) | |||||||||||||||||||||||
Domestic production activities deduction | — | — | (1.1) | |||||||||||||||||||||||
One-time U.S. tax benefit from internal reorganization of international subsidiaries | (13.1) | — | — | |||||||||||||||||||||||
State and local tax, net | (3.4) | 4.2 | 2.3 | |||||||||||||||||||||||
International permanent items | (5.2) | 7.5 | (1.6) | |||||||||||||||||||||||
Net impact of uncertain tax positions | 1.0 | (2.4) | (0.6) | |||||||||||||||||||||||
Changes in valuation allowances | 0.5 | 1.7 | (3.4) | |||||||||||||||||||||||
Other | 0.8 | — | 1.2 | |||||||||||||||||||||||
Effective income tax rate | 3.7 | % | 30.8 | % | 14.1 | % |
(In millions) |
2020
|
2019
|
||||||||||||
Deferred tax assets: | ||||||||||||||
Employment costs | 24.9 | 20.5 | ||||||||||||
Environmental reserves | 29.7 | 27.9 | ||||||||||||
Net operating loss carryforwards | 55.6 | 45.3 | ||||||||||||
Operating leases | 16.6 | 18.0 | ||||||||||||
Other, net | 43.9 | 40.1 | ||||||||||||
Gross deferred tax assets | $ | 170.7 | $ | 151.8 | ||||||||||
Valuation allowances | (20.7) | (16.2) | ||||||||||||
Total deferred tax assets, net of valuation allowances | $ | 150.0 | $ | 135.6 | ||||||||||
Deferred tax liabilities: | ||||||||||||||
Property, plant and equipment | $ | (47.6) | $ | (25.9) | ||||||||||
Goodwill and intangibles | (144.9) | (95.1) | ||||||||||||
Operating leases | (17.0) | (18.0) | ||||||||||||
Other, net | (2.4) | (9.2) | ||||||||||||
Total deferred tax liabilities | $ | (211.9) | $ | (148.2) | ||||||||||
Net deferred tax (liabilities) assets | $ | (61.9) | $ | (12.6) | ||||||||||
Consolidated Balance Sheets: | ||||||||||||||
Non-current deferred income tax assets | $ | 78.1 | $ | 50.9 | ||||||||||
Non-current deferred income tax liabilities | $ | (140.0) | $ | (63.5) |
Unrecognized Tax Benefits | ||||||||||||||||||||
(In millions) |
2020
|
2019
|
2018
|
|||||||||||||||||
Balance as of January 1, | $ | 11.2 | $ | 16.4 | $ | 17.8 | ||||||||||||||
Increases as a result of positions taken during current year | 0.6 | 1.1 | 1.3 | |||||||||||||||||
Increases as a result of positions taken for prior years | 0.6 | 0.4 | 1.1 | |||||||||||||||||
Reductions for tax positions of prior years | — | (0.7) | (2.6) | |||||||||||||||||
Decreases as a result of lapse of statute of limitations | (0.5) | (5.0) | (0.2) | |||||||||||||||||
Decreases relating to settlements with taxing authorities | (2.8) | — | (0.5) | |||||||||||||||||
Other, net | 0.4 | (1.0) | (0.5) | |||||||||||||||||
Balance as of December 31, | $ | 9.5 | $ | 11.2 | $ | 16.4 |
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Stock appreciation rights | $ | 4.4 | $ | 4.8 | $ | 4.2 | ||||||||||||||
Performance shares | 0.2 | 0.3 | 0.4 | |||||||||||||||||
Restricted stock units | 6.7 | 6.5 | 5.6 | |||||||||||||||||
Total share-based compensation | $ | 11.3 | $ | 11.6 | $ | 10.2 |
2020 | 2019 | 2018 | ||||||||||||||||||
Expected volatility | 33.0% | 40.0% | 41.0% | |||||||||||||||||
Expected dividends | 2.57% | 2.47% | 1.67% | |||||||||||||||||
Expected term (in years) | 6.9 | 6.6 | 6.5 | |||||||||||||||||
Risk-free rate | 1.56% | 2.78% | 3.06% | |||||||||||||||||
Value of SARs granted | $8.11 | $10.13 | $14.82 |
(In millions, except per share data) |
Shares | Weighted-Average Exercise Price per Share | Weighted-Average Remaining Contractual Term | Aggregate Intrinsic value | ||||||||||||||||||||||
Outstanding as of January 1, 2020 | 2.2 | $ | 32.04 | 6.6 | $ | 12.3 | ||||||||||||||||||||
Granted | 0.5 | 31.48 | ||||||||||||||||||||||||
Exercised | (0.1) | 17.95 | ||||||||||||||||||||||||
Forfeited or expired | — | 33.40 | ||||||||||||||||||||||||
Outstanding as of December 31, 2020 | 2.6 | $ | 32.43 | 6.4 | $ | 20.7 | ||||||||||||||||||||
Vested and exercisable as of December 31, 2020 | 1.3 | $ | 30.60 | 4.9 | $ | 13.0 | ||||||||||||||||||||
Year Ended December 31, 2020 (In millions) | Sales to External Customers | Intersegment Sales | Total Sales | Operating Income | Depreciation and Amortization | Capital Expenditures | ||||||||||||||||||||||||||||||||
Color, Additives and Inks | $ | 1,497.0 | $ | 5.9 | $ | 1,502.9 | $ | 180.8 | $ | 75.1 | $ | 30.5 | ||||||||||||||||||||||||||
Specialty Engineered Materials | 644.1 | 64.7 | 708.8 | 94.4 | 30.0 | 14.2 | ||||||||||||||||||||||||||||||||
Distribution | 1,087.4 | 22.9 | 1,110.3 | 69.5 | 0.7 | 1.4 | ||||||||||||||||||||||||||||||||
Corporate and eliminations | 13.6 | (93.5) | (79.9) | (155.4) | 9.2 | 17.6 | ||||||||||||||||||||||||||||||||
Total | $ | 3,242.1 | $ | — | $ | 3,242.1 | $ | 189.3 | $ | 115.0 | $ | 63.7 |
Year Ended December 31, 2019 (In millions) | Sales to External Customers | Intersegment Sales | Total Sales | Operating Income | Depreciation and Amortization | Capital Expenditures | ||||||||||||||||||||||||||||||||
Color, Additives and Inks | $ | 998.2 | $ | 5.6 | $ | 1,003.8 | $ | 147.4 | $ | 42.7 | $ | 21.5 | ||||||||||||||||||||||||||
Specialty Engineered Materials | 689.6 | 56.1 | 745.7 | 83.7 | 29.5 | 23.3 | ||||||||||||||||||||||||||||||||
Distribution | 1,172.9 | 19.3 | 1,192.2 | 75.4 | 0.5 | 1.6 | ||||||||||||||||||||||||||||||||
Corporate and eliminations | 2.0 | (81.0) | (79.0) | (149.7) | 5.4 | 21.2 | ||||||||||||||||||||||||||||||||
Total | $ | 2,862.7 | $ | — | $ | 2,862.7 | $ | 156.8 | $ | 78.1 | $ | 67.6 |
Year Ended December 31, 2018 (In millions) | Sales to External Customers | Intersegment Sales | Total Sales | Operating Income | Depreciation and Amortization | Capital Expenditures | ||||||||||||||||||||||||||||||||
Color, Additives and Inks | $ | 1,040.6 | $ | 5.9 | $ | 1,046.5 | $ | 158.5 | $ | 44.3 | $ | 22.9 | ||||||||||||||||||||||||||
Specialty Engineered Materials | 593.6 | 52.2 | 645.8 | 72.3 | 23.2 | 25.2 | ||||||||||||||||||||||||||||||||
Distribution | 1,246.8 | 18.6 | 1,265.4 | 71.5 | 0.7 | 0.1 | ||||||||||||||||||||||||||||||||
Corporate and eliminations | — | (76.7) | (76.7) | (123.7) | 4.4 | 8.3 | ||||||||||||||||||||||||||||||||
Total | $ | 2,881.0 | $ | — | $ | 2,881.0 | $ | 178.6 | $ | 72.6 | $ | 56.5 |
(In millions) | 2020 | 2019 | 2018 | |||||||||||||||||
Sales: | ||||||||||||||||||||
United States | $ | 1,619.7 | $ | 1,560.4 | $ | 1,543.1 | ||||||||||||||
Canada | 107.6 | 140.6 | 142.2 | |||||||||||||||||
Mexico | 236.2 | 261.2 | 296.5 | |||||||||||||||||
South America | 51.4 | 27.8 | 20.0 | |||||||||||||||||
Europe | 729.8 | 556.2 | 547.4 | |||||||||||||||||
Asia | 497.4 | 316.5 | 331.8 | |||||||||||||||||
Total Sales | $ | 3,242.1 | $ | 2,862.7 | $ | 2,881.0 | ||||||||||||||
(In millions) |
2020
|
2019
|
||||||||||||||||||
Total Assets: | ||||||||||||||||||||
Color, Additives and Inks | $ | 3,018.7 | $ | 1,215.8 | ||||||||||||||||
Specialty Engineered Materials | 728.1 | 774.0 | ||||||||||||||||||
Distribution | 244.9 | 235.6 | ||||||||||||||||||
Corporate and eliminations | 878.8 | 1,047.9 | ||||||||||||||||||
Total | $ | 4,870.5 | $ | 3,273.3 | ||||||||||||||||
(In millions) |
2020
|
2019
|
||||||||||||||||||
Property, net: | ||||||||||||||||||||
United States | $ | 261.8 | $ | 220.0 | ||||||||||||||||
Canada | 1.4 | 0.1 | ||||||||||||||||||
Mexico | 8.9 | 5.5 | ||||||||||||||||||
South America | 20.1 | 6.4 | ||||||||||||||||||
Europe | 224.5 | 98.1 | ||||||||||||||||||
Asia | 178.2 | 77.3 | ||||||||||||||||||
Total Long lived assets | $ | 694.9 | $ | 407.4 |
(In millions) | Balance Sheet Location | December 31, 2020 | December 31, 2019 | ||||||||||||||
Assets | |||||||||||||||||
Cross Currency Swaps (Net Investment Hedge)
|
Other non-current assets | $ | — | $ | 14.7 | ||||||||||||
Liabilities | |||||||||||||||||
Cross Currency Swaps (Net Investment Hedge)
|
Other non-current liabilities | $ | 41.1 | $ | — | ||||||||||||
Interest Rate Swap (Fair Value Hedge)
|
Other non-current liabilities | $ | 7.3 | $ | 5.1 |
2020 Quarters | 2019 Quarters | |||||||||||||||||||||||||||||||||||||||||||||||||
(In millions, except per share data) |
Fourth
|
Third
|
Second
|
First
|
Fourth
|
Third
|
Second
|
First
|
||||||||||||||||||||||||||||||||||||||||||
Sales | $ | 997.0 | $ | 924.5 | $ | 609.1 | $ | 711.5 | $ | 658.6 | $ | 705.3 | $ | 748.2 | $ | 750.6 | ||||||||||||||||||||||||||||||||||
Gross Margin | 252.9 | 210.2 | 149.7 | 171.5 | 153.3 | 160.5 | 175.3 | 168.1 | ||||||||||||||||||||||||||||||||||||||||||
Operating Income | 65.0 | 33.5 | 38.0 | 52.8 | 20.5 | 43.1 | 46.1 | 47.1 | ||||||||||||||||||||||||||||||||||||||||||
Net income (loss) from continuing operations | 74.7 | 2.6 | 23.4 | 33.1 | 6.4 | 23.6 | 23.2 | 22.5 | ||||||||||||||||||||||||||||||||||||||||||
Net income from continuing operations attributable to Avient Shareholders | 74.2 | 1.7 | 23.0 | 33.1 | 6.4 | 23.5 | 23.2 | 22.4 | ||||||||||||||||||||||||||||||||||||||||||
Income (loss) from discontinued operations, net of income taxes | 0.1 | — | (0.2) | (0.3) | 458.9 | 19.5 | 18.9 | 15.8 | ||||||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Avient common shareholders | $ | 74.3 | $ | 1.7 | $ | 22.8 | $ | 32.8 | $ | 465.3 | $ | 43.0 | $ | 42.1 | $ | 38.2 | ||||||||||||||||||||||||||||||||||
Earnings (loss) per share from continuing operations attributable to Avient shareholders: (1)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Basic earnings per share | $ | 0.81 | $ | 0.02 | $ | 0.25 | $ | 0.38 | $ | 0.08 | $ | 0.31 | $ | 0.30 | $ | 0.29 | ||||||||||||||||||||||||||||||||||
Diluted earnings per share | $ | 0.81 | $ | 0.02 | $ | 0.25 | $ | 0.38 | $ | 0.08 | $ | 0.30 | $ | 0.30 | $ | 0.29 | ||||||||||||||||||||||||||||||||||
Earnings (loss) per share from discontinued operations: (1)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Basic earnings per share | $ | — | $ | — | $ | — | $ | — | $ | 5.97 | $ | 0.25 | $ | 0.24 | $ | 0.20 | ||||||||||||||||||||||||||||||||||
Diluted earnings per share | $ | — | $ | — | $ | — | $ | — | $ | 5.92 | $ | 0.25 | $ | 0.24 | $ | 0.20 | ||||||||||||||||||||||||||||||||||
Total earnings (loss) per share attributable to Avient shareholders: (1)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Basic earnings per share | $ | 0.81 | $ | 0.02 | $ | 0.25 | $ | 0.38 | $ | 6.05 | $ | 0.56 | $ | 0.54 | $ | 0.49 | ||||||||||||||||||||||||||||||||||
Diluted earnings per share | $ | 0.81 | $ | 0.02 | $ | 0.25 | $ | 0.38 | $ | 6.00 | $ | 0.56 | $ | 0.54 | $ | 0.49 |
1. |
Avient’s management is responsible for establishing and maintaining adequate internal control over financial reporting.
|
||||
2. |
Under the supervision of and with participation of Avient’s management, including the Chief Executive Officer and the Chief Financial Officer, we conducted an evaluation of the effectiveness of internal control over financial reporting as of December 31, 2020 based on the guidelines established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) (2013 Framework). Management believes that the 2013 Framework is a suitable framework for its evaluation of financial reporting because it is free from bias, permits reasonably consistent qualitative and quantitative measurements of Avient’s internal control over financial reporting, is sufficiently complete so that those relevant factors that would alter a conclusion about the effectiveness of Avient’s internal control over financial reporting are not omitted and is relevant to an evaluation of internal control over financial reporting. Management's assessment of internal control over financial reporting as of December 31, 2020 excludes internal control over financial reporting related to Clariant MB (acquired July 1, 2020), which constituted approximately 41.6% of the Company's total assets (inclusive of acquired intangible assets) as of December 31, 2020, and approximately 16.8% of the Company's net sales for the year ended December 31, 2020.
|
||||
3. |
Based on the results of our evaluation, management has concluded that such internal control over financial reporting was effective as of December 31, 2020. There were no material weaknesses in internal control over financial reporting identified by management. The results of management's assessment were reviewed with our Audit Committee.
|
||||
4. |
Ernst & Young LLP, who audited the consolidated financial statements of Avient for the year ended December 31, 2020, also issued an attestation report on Avient’s internal control over financial reporting under Auditing Standard No. 2201 of the Public Company Accounting Oversight Board. This attestation report is set forth on page 32 of this Annual Report on Form 10-K and is incorporated by reference into this Item 9A.
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)
|
Weighted-average exercise price of outstanding options, warrants and rights |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))(2)
|
||||||||||||||||||
Plan category | (a) | (b) | (c) | |||||||||||||||||
Equity compensation plans approved by security holders
|
2,548,083 | $32.43 | 3,060,250 | |||||||||||||||||
Equity compensation plans not approved by security holders
|
— | — | — | |||||||||||||||||
Total | 2,548,083 | $32.43 | 3,060,250 |
Exhibit No. | Exhibit Description | ||||
101 .INS** | Inline XBRL Instance Document | ||||
101 .SCH** | Inline XBRL Taxonomy Extension Schema Document | ||||
101 .CAL** | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
101 .LAB** | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
101 .PRE** | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
101 .DEF** | Inline XBRL Taxonomy Definition Linkbase Document | ||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
+ | Indicates management contract or compensatory plan, contract or arrangement in which one or more directors or executive officers of the Registrant may be participants |
† | Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request. |
** |
Filed herewith.
|
AVIENT CORPORATION | |||||||||||||||||
February 25, 2021 | BY: | /S/ JAMIE A. BEGGS | |||||||||||||||
Jamie A. Beggs Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer) |
Signature and Title | ||||||||||||||
/S/ ROBERT M. PATTERSON |
Chairman, President and Chief Executive Officer
(Principal Executive Officer) |
February 25, 2021 | ||||||||||||
Robert M. Patterson | ||||||||||||||
/S/ JAMIE A. BEGGS |
Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer) |
February 25, 2021 | ||||||||||||
Jamie A. Beggs | ||||||||||||||
/S/ ROBERT E. ABERNATHY | Director | February 25, 2021 | ||||||||||||
Robert E. Abernathy
|
||||||||||||||
/S/ RICHARD H. FEARON | Director | February 25, 2021 | ||||||||||||
Richard H. Fearon | ||||||||||||||
/S/ GREGORY J. GOFF | Director | February 25, 2021 | ||||||||||||
Gregory J. Goff | ||||||||||||||
/S/ WILLIAM R. JELLISON | Director | February 25, 2021 | ||||||||||||
William R. Jellison | ||||||||||||||
/S/ SANDRA BEACH LIN | Director | February 25, 2021 | ||||||||||||
Sandra Beach Lin | ||||||||||||||
/S/ KIM ANN MINK | Director | February 25, 2021 | ||||||||||||
Kim Ann Mink | ||||||||||||||
/S/ KERRY J. PREETE | Director | February 25, 2021 | ||||||||||||
Kerry J. Preete | ||||||||||||||
/S/ PATRICIA VERDUIN | Director | February 25, 2021 | ||||||||||||
Patricia Verduin | ||||||||||||||
/S/ WILLIAM A. WULFSOHN | Director | February 25, 2021 | ||||||||||||
William A. Wulfsohn |
SCHEDULE OF EXECUTIVES WITH MANAGEMENT CONTINUITY AGREEMENTS | ||||||||||||||||||||
Title | Name | Years / Comp* | Excise Tax Gross Up? | |||||||||||||||||
Chairman, President and Chief Executive Officer | Robert M. Patterson | 3 | Y | |||||||||||||||||
Senior Vice President, Chief Financial Officer | Jamie A. Beggs | 2 | N | |||||||||||||||||
Senior Vice President, President of Distribution | Cathy K. Dodd | 2 | N | |||||||||||||||||
Senior Vice President, President, Color, Additives and Inks, EMEA | Michael A. Garratt | 2 | N | |||||||||||||||||
Senior Vice President, General Counsel and Secretary | Lisa K. Kunkle | 3 | Y | |||||||||||||||||
Senior Vice President, Global Operations and Process Improvement | M. John Midea, Jr. | 2 | N | |||||||||||||||||
Senior Vice President, President of Color, Additives and Inks, Americas and Asia | Woon Keat Moh | 2 | N | |||||||||||||||||
Senior Vice President, President of Specialty Engineered Materials | Christopher L. Pederson | 2 | N | |||||||||||||||||
Senior Vice President, Mergers & Acquisitions | Joel R. Rathbun | 2 | N | |||||||||||||||||
Senior Vice President, Chief Human Resources Officer | João José San Martin Neto | 2 | N |
Performance Period | Allocation of Performance Units | ||||
Performance Period #1:
January 1, 2021 to December 31, 2021 |
25% | ||||
Performance Period #2:
January 1, 2022 to December 31, 2022 |
25% | ||||
Performance Period #3:
January 1, 2023 to December 31, 2023 |
25% | ||||
Performance Period #4:
January 1, 2021 to December 31, 2023 |
25% |
Exhibit 21.1 | ||||||||
SUBSIDIARIES OF THE COMPANY | ||||||||
Name | Formation Jurisdiction | |||||||
ACP Solutions Southern Africa (PTY) LTD | South Africa | |||||||
Altona Properties Pty Ltd. (37.4% owned) | Australia | |||||||
Auseon Limited | Australia | |||||||
Avient Colorants Belgium SA (f/k/a Clariant Plastics & Coatings SA) | Belgium | |||||||
Avient Colorants Italy Srl (f/k/a Clariant Plastics & Coatings (Italia) S.p.A.) | Italy | |||||||
Avient Colorants Spain S.A. (f/k/a Clariant Plastics & Coatings (Ibérica) S.A.) | Spain | |||||||
Avient Colorants Sweden AB (f/k/a Clariant Plastics & Coatings (Nordic) AB) | Sweden | |||||||
Avient Colorants Switzerland AG (f/k/a Performance Masterbatches Switzerland AG) | Switzerland | |||||||
Avient Finland OY (f/k/a Clariant Plastics & Coatings (Finland) OY) | Finland | |||||||
Avient Luxembourg S.à r.l. (f/k/a PolyOne Luxembourg S.à r.l) | Luxembourg | |||||||
Avient Pakistan (Private) Limited (f/k/a Clariant Chemical Pakistan (Pvt) Ltd. | Pakistan | |||||||
Avient Puerto Rico, LLC (f/k/a PolyOne Puerto Rico, LLC) | Puerto Rico | |||||||
Avient Switzerland GmbH (f/k/a Clariant Plastics & Coating AG) | Switzerland | |||||||
Braspenco Indústria de Compostos de Plásticos Ltda. | Brazil | |||||||
Burton Rubber Company | Delaware | |||||||
Butler Brothers, Inc. (49% owned) | Minnesota | |||||||
Chromatics, Inc. | Connecticut | |||||||
Clariant (Guatemala) S.A. | Guatemala | |||||||
Clariant (New Zealand) Ltd. | New Zealand | |||||||
Clariant Turkey Plastik, Boya ve Kimyevi Maddeler Sanayi | Turkey | |||||||
Clariant (Vietnam) Ltd. | Vietnam | |||||||
Clariant Masterbatches (Malaysia) Sdn Bhd | Malaysia | |||||||
Clariant Masterbatches (Saudi Arabia) Ltd. | Saudi Arabia | |||||||
Clariant Masterbatches (Shanghai) Ltd. | China | |||||||
Clariant Material Science (Guangzhou) Ltd. | China | |||||||
Clariant Plastics & Coatings (Argentina) S.A. | Argentina | |||||||
Clariant Plastics & Coatings (Colombia) S.A.S. | Colombia | |||||||
Clariant Plastics & Coatings (France) | France | |||||||
Clariant Plastics & Coatings (Ireland) Ltd. | Ireland | |||||||
Clariant Plastics & Coatings (Italia) S.p.A. | Italy | |||||||
Clariant Plastics & Coatings (Polska) Sp. z.o.o. | Poland | |||||||
Clariant Plastics & Coatings (Taiwan) Co., Ltd. | Taiwan | |||||||
Clariant Plastics & Coatings (Thailand) Ltd. | Thailand | |||||||
Clariant Plastics & Coatings (The Netherlands) B.V. | Netherlands | |||||||
Clariant Plastics & Coatings (UK) Ltd. | United Kingdom | |||||||
Clariant Plastics & Coatings Brasil Indústria Qúimica Ltda. | Brazil | |||||||
Clariant Plastics & Coatings Canada Inc. | Canada | |||||||
Clariant Plastics and Coatings FZE | United Arab Emirates | |||||||
Clariant Plastics and Coatings (RUS) LLC | Russia | |||||||
Clariant Plastics & Coatings USA LLC | Delaware | |||||||
Colorant Chromatics AB | Finland | |||||||
Colorant Chromatics AG | Switzerland | |||||||
Colorant Chromatics Europe B.V. | Netherlands | |||||||
Colorant Chromatics Trading Shanghai, Ltd. | China | |||||||
Colorant GmbH | Germany | |||||||
ColorMatrix Argentina S.A. | Argentina |
Name | Formation Jurisdiction | |||||||
ColorMatrix Asia Limited | Hong Kong | |||||||
ColorMatrix-Brazil, LLC | Ohio | |||||||
ColorMatrix Corporation, The | Ohio | |||||||
ColorMatrix do Brasil Indústria e Comércio de Pigmentos e Aditivos Ltda. | Brazil | |||||||
ColorMatrix Europe BV | Netherlands | |||||||
ColorMatrix Europe Limited | United Kingdom | |||||||
ColorMatrix Group, Inc. | Delaware | |||||||
ColorMatrix Holdings, Inc. | Delaware | |||||||
ColorMatrix Plastic Colorant (Suzhou) Co. Ltd. | China | |||||||
ColorMatrix Russia LLC | Russia | |||||||
ColorMatrix South Africa (Pty) Ltd. | South Africa | |||||||
ColorMatrix UK Holdings Limited | United Kingdom | |||||||
ColorMatrix UK Limited | United Kingdom | |||||||
COMPTEK Kunststoffverarbeitung GmbH | Germany | |||||||
Conexus, LLC | Nevada | |||||||
Fiber-Line Asia Pacific B.V. | Netherlands | |||||||
Fiber-Line Asia Pacific (Changzhou) Co., Ltd. | China | |||||||
Fiber-Line Asia Pacific (Shanghai) Co., Ltd. | China | |||||||
Fiber-Line Holding B.V. | Netherlands | |||||||
Fiber-Line International B.V. | Netherlands | |||||||
Fiber-Line, LLC | Delaware | |||||||
Fiber-Line Management, Inc. | Delaware | |||||||
Franklin-Burlington Plastics, Inc. | Delaware | |||||||
Glasforms, Inc. | California | |||||||
GLS Hong Kong Limited | Hong Kong | |||||||
GLS International, Inc. | Illinois | |||||||
GLS Thermoplastic Alloys (Suzhou) Co., Ltd. | China | |||||||
GLS Trading (Suzhou) Co., Ltd. | China | |||||||
GSDI Specialty Dispersions, Inc. | Ohio | |||||||
Hanna France S.à r.l. | France | |||||||
Hanna-Itasca Company | Delaware | |||||||
Hanna Proprietary Limited | Delaware | |||||||
Hansand Steamship Company (33% owned) | Delaware | |||||||
IQAP Czech, s.r.o. | Czech Republic | |||||||
IQAP Masterbatch Group, S.L. | Spain | |||||||
Juffali-PolyOne Master Batches Company (51% owned) | Saudi Arabia | |||||||
Kimberly Iron (14% owned) | Michigan | |||||||
Laconian Holding Company | Missouri | |||||||
L. E. Carpenter & Company | Delaware | |||||||
MAG International (50% owned) | Delaware | |||||||
Magenta Master Fibers S.r.l. | Italy | |||||||
Magenta Master Fibers (Shanghai) Co., Ltd. | China | |||||||
M.A. Hanna Asia Holding Company | Delaware | |||||||
M.A. Hanna Export Services Corp. | Barbados | |||||||
M.A. Hanna Plastic Group, Inc. | Michigan | |||||||
NEU Specialty Engineered Materials, LLC | Ohio |
Name | Formation Jurisdiction | |||||||
O’Sullivan Plastics, LLC | Nevada | |||||||
Paramont Coal Company (50% owned) | Virginia | |||||||
Performance Masterbatches (Chile) S.p.A. | Chile | |||||||
Performance Masterbatches (Japan) K.K. | Japan | |||||||
Performance Masterbatches Austria GmbH | Austria | |||||||
Performance Masterbatches Germany GmbH | Germany | |||||||
Performance Masterbatches MX, S.A. de C.V. | Mexico | |||||||
Performance Masterbatches Serv, S. de R.L. de C.V. | Mexico | |||||||
Performance Masterbatches Singapore Pte. Ltd. | Singapore | |||||||
Pilot Knob Pellet Co. (50% owned) | Missouri | |||||||
PlastiComp Europe GmbH | Germany | |||||||
PlastiComp, Inc. | Minnesota | |||||||
POL Development, Inc. (f/k/a Geon Development, Inc.) | Ohio | |||||||
POL Laconian de Mexico Holding Company, S de R.L. de C.V. | Mexico | |||||||
POL Luxembourg Holding Company, S.a r.l | Luxembourg | |||||||
POL Mexico Holdings, LLC | Missouri | |||||||
Polymer Diagnostics, Inc. | Ohio | |||||||
PolyOne Belgium S.A. | Belgium | |||||||
PolyOne Canada ULC | Canada | |||||||
PolyOne Canada-Australia S.à r.l. | Luxembourg | |||||||
PolyOne Chuzhou Co., Ltd. | China | |||||||
PolyOne Color and Additives Germany, GmbH | Germany | |||||||
PolyOne Company Australia Limited, The (f/k/a The Geon Company Australia Limited) | Australia | |||||||
PolyOne Corporation UK Limited | United Kingdom | |||||||
PolyOne Costa Rica S.A. | Costa Rica | |||||||
PolyOne CR s.r.o. | Czech Republic | |||||||
PolyOne de Mexico Distribution, S. de R.L. de C.V. | Mexico | |||||||
PolyOne de Mexico S.A. de C.V. | Mexico | |||||||
PolyOne Deutschland, GmbH | Germany | |||||||
PolyOne Distribution Trading (Shanghai) Co. Ltd. | China | |||||||
PolyOne Engineered Films, LLC | Virginia | |||||||
PolyOne España, S.L. | Spain | |||||||
PolyOne Europe Inc. (duly incorporated with PolyOne Europe S.à r.l.) | Delaware | |||||||
PolyOne Europe Finance S.à r.l. | Luxembourg | |||||||
PolyOne Europe Logistics S.A. | Belgium | |||||||
PolyOne Europe S.à r.l. (duly incorporated with PolyOne Europe Inc.) | Luxembourg | |||||||
PolyOne Finance Ltd. | Cyprus | |||||||
PolyOne France S.A.S. | France | |||||||
PolyOne Funding Corporation | Delaware | |||||||
PolyOne Global S.à r.l. | Luxembourg | |||||||
PolyOne Hong Kong Holding Limited | Hong Kong | |||||||
PolyOne Hungary, Ltd. | Hungary | |||||||
PolyOne Intellectual Property Ltd. | Cyprus | |||||||
PolyOne International Finance Unlimited Company | Ireland | |||||||
PolyOne International Ltd. | British Virgin Islands | |||||||
PolyOne International Real Estate Corporation | Ohio | |||||||
PolyOne International S.à r.l. | Luxembourg | |||||||
PolyOne International Trading (Shanghai) Co., Ltd. | China |
Name | Formation Jurisdiction | |||||||
Polyone Italy S.r.l. | Italy | |||||||
PolyOne Japan K.K. | Japan | |||||||
PolyOne Korea, Ltd. | Korea | |||||||
PolyOne Limited | Cyprus | |||||||
PolyOne LLC | Delaware | |||||||
PolyOne Management (Shanghai) Co. Ltd. | China | |||||||
PolyOne Poland Manufacturing, Sp.z.o.o. | Poland | |||||||
PolyOne Polimeks Plastik Tic. ve San. A.Ş | Turkey | |||||||
PolyOne Polymer (Tianjin) Co., Ltd. | China | |||||||
PolyOne Polymers India Pvt. Ltd. | India | |||||||
PolyOne S.à r.l. | Luxembourg | |||||||
PolyOne (Shanghai) Co., Ltd. (a/k/a PolyOne Shanghai, China) | China | |||||||
PolyOne Shenzhen Co. Ltd. | China | |||||||
PolyOne Singapore Pte Ltd | Singapore | |||||||
PolyOne Suzhou, China | China | |||||||
PolyOne Sweden, A.B. | Sweden | |||||||
PolyOne Tekno Polimer Mühendislik Plastikleri San. ve Tic. A.S. | Turkey | |||||||
PolyOne Tekno Ticaret Mühendislik Plastikleri San. ve Tic. A.S. | Turkey | |||||||
PolyOne Termoplásticos do Brasil Ltda. | Brazil | |||||||
PolyOne Th. Bergmann GmbH | Germany | |||||||
PolyOne (Thailand) Co., Ltd. | Thailand | |||||||
PolyOne UK Finance Limited | United Kingdom | |||||||
P.T. Clariant Plastics and Coating Indonesia | Indonesia | |||||||
RA Products, Inc. | Michigan | |||||||
Regalite Plastics, LLC | Massachusetts | |||||||
Rutland DCC Inc Manufacturing Private Limited (50 % owned) | India | |||||||
Rutland Europe Limited | United Kingdom | |||||||
Rutland Group, Inc. | Delaware | |||||||
Rutland Holding Company | Delaware | |||||||
Rutland Intermediate Holding Company | Delaware | |||||||
Rutland International Limited | United Kingdom | |||||||
Rutland Plastics, Inc. | Florida | |||||||
Seola ApS | Denmark | |||||||
Servicios Factoria Barbastro, S.A. (50% owned) | Spain | |||||||
Shanghai Colorant Chromatics Co., Ltd. | China | |||||||
Shawnee Holdings, LLC | Virginia | |||||||
SilCoTec, Inc. | Indiana | |||||||
Sociedad Quimica Alemana S.A. | Peru | |||||||
Spartech, S.A.S. | France | |||||||
Uniplen Indústria de Polimeros Ltda. | Brazil |
(1) |
Registration Statement (Form S-8 No. 333-238246) pertaining to the PolyOne Corporation 2020 Equity and Incentive Compensation Plan;
|
||||||||||
(2) |
Registration Statement (Form S-8 No. 333-231236) pertaining to the PolyOne Supplemental Retirement Benefit Plan (As Amended and Restated Effective January 1, 2014);
|
||||||||||
(3) |
Registration Statement (Form S-8 No. 333-217879) pertaining to the PolyOne Corporation 2017 Equity and Incentive Compensation Plan;
|
||||||||||
(4) |
Registration Statement (Form S-8 No. 333-205919) pertaining to the Amended and Restated PolyOne Corporation 2010 Equity and Performance Incentive Plan;
|
||||||||||
(5) |
Registration Statement (Form S-8 No. 333-181787) pertaining to the PolyOne Corporation 2010 Equity and Performance Incentive Plan;
|
||||||||||
(6) |
Registration Statement (Form S-8 No. 333-166775) pertaining to the PolyOne Corporation 2010 Equity and Performance Incentive Plan;
|
||||||||||
(7) |
Registration Statement (Form S-8 No. 333-157486) pertaining to the PolyOne Retirement Savings Plan;
|
||||||||||
(8) |
Registration Statement (Form S-8 No. 333-47796) pertaining to Post-Effective Amendment No. 3 on Form S-8 to Form S-4 pertaining to the Geon Company 1993 Incentive Stock Plan, the Geon Company 1995 Incentive Stock Plan, the Geon Company 1998 Interim Stock Award Plan, the Geon Company 1999 Incentive Stock Plan, the PolyOne Corporation Deferred Compensation Plan for Non-Employee Directors and the M.A. Hanna Company Long-Term Incentive Plan;
|
||||||||||
(9) |
Registration Statement (Form S-8 No. 333-141029) pertaining to the PolyOne Retirement Savings Plan and the DH Compounding Company Savings and Retirement Plan and Trust; and
|
||||||||||
(10) |
Registration Statement (Form S-3 No. 333-236116) of PolyOne Corporation of our reports dated February 24, 2021, with respect to the consolidated financial statements of Avient Corporation and the effectiveness of internal control over financial reporting of Avient Corporation, included in this Annual Report (Form 10-K) of Avient Corporation for the year ended December 31, 2020.
|
/s/ Robert M. Patterson | |||||
Robert M. Patterson
Chairman, President and Chief Executive Officer |
/s/ Jamie A. Beggs | |||||
Jamie A. Beggs
Senior Vice President and Chief Financial Officer |
/s/ Robert M. Patterson | |||||
Robert M. Patterson
Chairman, President and Chief Executive Officer |
/s/ Jamie A. Beggs | |||||
Jamie A. Beggs
Senior Vice President and Chief Financial Officer |